data_1d0r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d0r _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.423 0.63 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 120.317 0.103 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.473 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' NZ ' ' OE1' ' A' ' 17' ' ' GLN . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 . . . . . 0 N--CA 1.477 0.877 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 . . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.436 0.636 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 . . . . . 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.0 0.428 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.591 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.426 1.1 t0 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 4.7 pt-20 . . . . . 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.613 0.721 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.581 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.484 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 31.9 mt-10 . . . . . 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 21' ' ' GLU . 2.2 tm0? -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 20' ' ' LYS . 4.5 mt-10 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 10' ' ' VAL 0.255 1.5 p30 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.272 6.1 t0 . . . . . 0 N--CA 1.505 2.321 0 CA-C-O 122.641 1.21 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.458 HE21 ' CG ' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.458 ' CG ' HE21 ' A' ' 17' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 . . . . . 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 124.128 1.918 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB3' ' CG ' ' A' ' 21' ' ' GLU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.88 1.324 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 13' ' ' TYR . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' GLY . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.468 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 . . . . . 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 17.2 mp0 . . . . . 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 31.8 t60 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 114.628 -2.606 . . . . 0.0 106.053 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 109.57 73.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.251 0.5 OUTLIER -1.28 86.62 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.825 1 CA-C-O 128.655 4.074 . . . . 0.0 117.568 -179.557 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 6' ' ' PHE . . . 140.11 -77.82 0.31 Allowed Glycine 0 N--CA 1.495 2.607 2 N-CA-C 97.75 -6.14 . . . . 0.0 97.75 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 50.4 m -20.51 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 126.456 1.903 . . . . 0.0 116.086 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 8' ' ' SER . 7.3 t80 77.04 -65.65 0.28 Allowed 'General case' 0 N--CA 1.511 2.585 0 C-N-CA 126.472 1.909 . . . . 0.0 109.068 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -14.89 -48.32 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.809 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' PHE . 32.7 t -36.52 -55.61 0.84 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 113.857 -1.519 . . . . 0.0 112.874 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 -49.85 -80.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.396 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 28' ' ' LYS . 10.1 tp10 -34.79 -55.9 0.56 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -83.25 -45.43 13.84 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.836 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -41.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-O 123.199 1.476 . . . . 0.0 110.402 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.2 -36.71 14.62 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.585 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -31.22 -58.47 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 CA-C-O 123.162 1.458 . . . . 0.0 113.96 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.1 mt -43.29 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 29' ' ' GLY . 87.6 t -117.09 -50.89 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 2.8 tmmt? -83.22 48.0 1.32 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 124.472 2.082 . . . . 0.0 106.842 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . -133.26 -15.62 1.28 Allowed Glycine 0 N--CA 1.503 3.138 0 CA-C-N 111.407 -2.633 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.173 0 O-C-N 126.384 1.873 . . . . 0.0 108.723 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.449 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 115.658 -2.115 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.44 -71.07 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 120.996 1.726 . . . . 0.0 113.867 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -101.05 -65.15 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' O ' ' N ' ' A' ' 1' ' ' HIS . . . -68.18 89.69 0.21 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.516 HG23 ' CG ' ' A' ' 6' ' ' PHE . 12.7 t 126.5 -158.56 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 130.6 3.56 . . . . 0.0 105.438 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' CG ' HG23 ' A' ' 5' ' ' THR . 5.9 p90 -23.26 71.27 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.4 m 165.41 -70.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 128.923 2.889 . . . . 0.0 105.231 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -56.24 -59.43 4.95 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.389 -0.82 . . . . 0.0 109.589 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -48.12 -51.8 23.19 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.473 ' OE1' ' NZ ' ' A' ' 20' ' ' LYS . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' NZ ' ' OE1' ' A' ' 17' ' ' GLN . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -51.05 -21.93 2.11 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 68.0 t80 -95.51 -57.51 2.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.41 -38.6 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 122.937 1.351 . . . . 0.0 110.814 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.39 36.93 1.05 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 122.493 1.14 . . . . 0.0 109.358 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.451 ' HB3' ' O ' ' A' ' 22' ' ' PHE . 27.5 t90 -114.14 -83.59 0.61 Allowed 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 122.95 1.357 . . . . 0.0 109.936 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 26' ' ' LEU . 1.1 pt? -51.12 -9.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.83 15.84 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.083 0 CA-C-O 123.548 1.642 . . . . 0.0 110.486 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.69 -48.58 0.25 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.185 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.67 53.03 0.83 Allowed Glycine 0 N--CA 1.513 3.804 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.782 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.507 2.399 0 CA-C-O 115.281 -2.295 . . . . 0.0 110.668 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.439 ' H1 ' ' C ' ' A' ' 7' ' ' THR . 24.9 p80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 -55.13 1.15 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 101.666 -3.457 . . . . 0.0 101.666 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.74 50.61 2.03 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 111.557 -2.565 . . . . 0.0 107.143 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 8.98 -98.7 0.01 OUTLIER Glycine 1 N--CA 1.527 4.713 0 CA-C-N 113.289 -1.778 . . . . 0.0 116.255 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -39.46 -27.14 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.515 ' HA ' ' CG1' ' A' ' 10' ' ' VAL . 12.1 m-85 -107.89 -5.5 17.17 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 125.037 2.351 . . . . 0.0 114.338 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.439 ' C ' ' H1 ' ' A' ' 1' ' ' HIS . 7.3 t 10.2 26.16 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.251 1 N-CA-C 126.621 5.786 . . . . 0.0 126.621 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t 76.54 16.48 2.01 Favored 'General case' 0 N--CA 1.535 3.793 0 CA-C-O 124.596 2.141 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.643 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 -125.68 -91.41 0.53 Allowed 'General case' 0 C--N 1.29 -1.995 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 -179.998 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.515 ' CG1' ' HA ' ' A' ' 6' ' ' PHE . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 53.3 mm-40 -44.98 -62.48 1.22 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.94 38.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 124.802 2.239 . . . . 0.0 112.007 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.497 ' H ' ' C ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -127.07 -47.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.04 -53.51 10.95 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.568 -2.105 . . . . 0.0 112.019 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 44.6 m0 -23.66 -55.01 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 123.435 1.588 . . . . 0.0 114.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.84 73.62 1.58 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 112.6 -2.091 . . . . 0.0 112.658 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 18.1 m 45.32 28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 110.658 -2.974 . . . . 0.0 113.84 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.51 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 73.05 43.45 0.4 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.39 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.25 -49.36 0.08 OUTLIER Glycine 0 N--CA 1.505 3.257 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.568 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.577 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.658 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.581 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.51 ' CG ' ' HB3' ' A' ' 6' ' ' PHE . 54.2 m170 . . . . . 0 N--CA 1.507 2.383 0 CA-C-O 116.569 -1.682 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -39.69 151.72 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.935 1.243 . . . . 0.0 110.595 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 36.18 25.68 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 CA-C-O 124.894 2.283 . . . . 0.0 115.651 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.5 -68.63 0.42 Allowed Glycine 0 N--CA 1.512 3.738 0 O-C-N 119.601 -1.937 . . . . 0.0 112.483 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 p 20.6 -101.28 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.419 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' HB3' ' CG ' ' A' ' 1' ' ' HIS . 62.1 t80 -69.55 108.07 3.66 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.382 -1.449 . . . . 0.0 108.655 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t 173.51 -38.08 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 111.153 -2.749 . . . . 0.0 105.752 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -26.02 -55.14 0.06 Allowed 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 112.92 -1.945 . . . . 0.0 115.624 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 -60.18 -86.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.095 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 19.2 tp10 -48.99 -53.09 21.4 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HA ' ' CG ' ' A' ' 25' ' ' TRP . 15.7 t80 -63.41 -46.73 85.04 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 123.628 1.68 . . . . 0.0 106.717 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.58 -14.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.442 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.15 -35.41 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.299 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 41.7 m0 -28.6 -66.85 0.08 Allowed 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -43.45 -18.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 111.448 -2.614 . . . . 0.0 115.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -114.49 -44.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 61.6 mtpt -51.44 -46.08 62.89 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.768 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 30' ' ' ARG . . . -141.11 -30.16 0.17 Allowed Glycine 0 N--CA 1.513 3.775 0 CA-C-N 113.765 -1.561 . . . . 0.0 115.127 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.512 ' NH1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.536 0 C-N-CA 129.282 3.033 . . . . 0.0 105.932 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.402 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 52.5 m-70 . . . . . 0 N--CA 1.506 2.368 0 CA-C-O 122.699 1.238 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.561 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -137.81 -53.46 0.65 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 6.5 mp0 -5.54 -60.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 112.079 -2.328 . . . . 0.0 116.606 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.91 55.56 4.91 Favored Glycine 0 N--CA 1.51 3.623 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.353 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 m 66.4 -33.12 0.19 Allowed 'General case' 0 N--CA 1.528 3.447 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 7' ' ' THR . 9.1 t80 40.78 -102.35 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.413 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.489 ' N ' ' CG ' ' A' ' 6' ' ' PHE . 57.0 p 4.11 -75.85 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.792 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.5 m -32.43 -42.42 0.07 Allowed 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -28.36 -49.61 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.008 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.426 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -48.23 2.97 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -54.03 -44.4 70.95 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.404 HG21 ' N ' ' A' ' 24' ' ' ALA . 8.4 tp -43.33 -49.41 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 112.024 -2.353 . . . . 0.0 110.5 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' N ' HG21 ' A' ' 23' ' ' ILE . . . -62.77 -47.48 83.32 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.194 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 1.5 t90 -46.96 -36.04 7.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.438 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -107.8 33.58 4.0 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 124.389 2.043 . . . . 0.0 114.917 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.4 t -130.13 -50.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.077 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 25' ' ' TRP . 4.6 pttt -19.79 -53.35 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.21 44.61 1.15 Allowed Glycine 0 N--CA 1.515 3.962 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.623 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.518 ' C ' HH21 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.162 0 O-C-N 125.449 1.323 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.429 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 22.7 m170 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 122.499 1.143 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.522 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -150.01 -65.04 0.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -33.89 -48.96 0.32 Allowed 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.371 179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -26.93 -39.26 0.01 OUTLIER Glycine 0 N--CA 1.516 3.985 0 N-CA-C 117.91 1.924 . . . . 0.0 117.91 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 7' ' ' THR . 67.5 p -106.35 19.95 19.72 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 8' ' ' SER . 36.2 p90 6.64 -54.63 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 121.512 3.893 . . . . 0.0 121.512 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 8' ' ' SER . 1.3 t 38.17 -65.02 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 6' ' ' PHE . 12.0 m -91.43 -36.85 13.54 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -50.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' ' CG1' ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.591 ' HA ' ' NZ ' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.35 -41.99 90.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.85 -46.32 88.45 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -52.08 -52.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 117.841 -1.543 . . . . 0.0 108.388 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.5 -50.65 9.38 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.142 -0.974 . . . . 0.0 110.676 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -30.55 -54.13 0.19 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 124.427 2.06 . . . . 0.0 113.341 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.17 -23.91 13.22 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.603 -2.999 . . . . 0.0 118.278 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.469 ' N ' HD21 ' A' ' 26' ' ' LEU . 21.1 m -82.08 -27.51 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 CA-C-N 120.758 1.617 . . . . 0.0 108.275 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.36 -24.18 2.31 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 118.334 2.716 . . . . 0.0 118.334 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.53 50.65 0.79 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.561 1.163 . . . . 0.0 114.994 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.503 ' N ' ' OG1' ' A' ' 5' ' ' THR . 37.9 m170 . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.451 ' HB2' ' CE2' ' A' ' 6' ' ' PHE . . . 110.89 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 127.649 2.38 . . . . 0.0 104.971 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -89.8 58.48 4.26 Favored 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -128.97 6.48 Favored Glycine 0 N--CA 1.51 3.578 0 N-CA-C 105.092 -3.203 . . . . 0.0 105.092 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.503 ' OG1' ' N ' ' A' ' 1' ' ' HIS . 30.9 m -142.96 48.66 1.49 Allowed 'General case' 0 N--CA 1.525 3.304 0 O-C-N 120.745 -1.444 . . . . 0.0 112.543 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' CE2' ' HB2' ' A' ' 2' ' ' ALA . 10.5 m-30 -12.75 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -33.16 -48.43 0.22 Allowed 'General case' 0 N--CA 1.528 3.445 0 CA-C-O 122.862 1.315 . . . . 0.0 113.815 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -106.96 -44.64 4.36 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 112.425 -2.17 . . . . 0.0 108.959 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HB3' ' CA ' ' A' ' 6' ' ' PHE 0.426 1.1 t0 -47.91 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.705 -2.043 . . . . 0.0 107.374 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 4.7 pt-20 -102.46 -41.53 6.27 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.9 t80 -57.95 -39.9 79.23 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.7 mt -52.44 -44.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.025 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.34 -58.26 8.47 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.634 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.592 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -31.0 -49.99 0.14 Allowed 'General case' 0 N--CA 1.521 3.123 0 CA-C-O 125.093 2.377 . . . . 0.0 113.404 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.304 62.4 tp -100.3 -16.39 17.7 Favored 'General case' 0 C--N 1.288 -2.083 1 CA-C-N 108.117 -4.129 . . . . 0.0 120.687 -178.97 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.9 t -84.86 -31.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.226 -0.921 . . . . 0.0 110.498 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.556 ' HZ2' ' C ' ' A' ' 30' ' ' ARG . 0.4 OUTLIER 139.86 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.583 1.953 . . . . 0.0 111.73 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.6 -40.43 2.6 Favored Glycine 1 N--CA 1.523 4.462 0 C-N-CA 119.64 -1.267 . . . . 0.0 115.752 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.556 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 C-N-CA 126.24 1.816 . . . . 0.0 107.716 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 43.3 t60 . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.671 ' H ' ' CG ' ' A' ' 1' ' ' HIS . . . -29.77 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-N 123.907 3.049 . . . . 0.0 117.289 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' OE2' ' N ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -84.02 -5.13 59.17 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 118.945 2.942 . . . . 0.0 118.945 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 17.64 46.45 0.01 OUTLIER Glycine 1 N--CA 1.524 4.53 0 N-CA-C 117.544 1.778 . . . . 0.0 117.544 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -127.75 -156.39 0.75 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 8' ' ' SER . 67.9 m-85 67.29 -71.93 0.1 Allowed 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.591 1.156 . . . . 0.0 111.427 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p 41.24 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' PHE . 65.1 m -35.36 -38.46 0.1 Allowed 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 126.92 2.088 . . . . 0.0 115.326 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 -95.11 -65.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.415 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.581 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.484 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' N ' ' CD ' ' A' ' 15' ' ' GLU . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 31.9 mt-10 -62.47 -36.94 84.06 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.3 t80 -65.12 -44.0 90.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 26' ' ' LEU . 93.1 mt -53.4 -47.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.13 -49.88 40.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.441 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -50.92 -67.72 0.23 Allowed 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 124.95 2.309 . . . . 0.0 107.769 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HB3' ' O ' ' A' ' 23' ' ' ILE 0.297 4.2 tt -31.23 -40.38 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 108.892 -3.776 . . . . 0.0 113.003 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -100.87 -41.86 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -122.62 17.04 10.38 Favored 'General case' 0 N--CA 1.521 3.091 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.48 -54.14 0.15 Allowed Glycine 1 N--CA 1.525 4.575 0 N-CA-C 106.194 -2.763 . . . . 0.0 106.194 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.57 1 C-N-CA 131.989 4.115 . . . . 0.0 111.643 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.547 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 58.7 t-80 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.472 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -66.3 170.85 5.38 Favored 'General case' 0 CA--C 1.588 2.422 1 N-CA-C 98.651 -4.574 . . . . 0.0 98.651 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 26.33 12.51 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 121.217 3.784 . . . . 0.0 121.217 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . -155.5 76.63 0.21 Allowed Glycine 0 N--CA 1.509 3.511 0 O-C-N 119.842 -1.786 . . . . 0.0 113.459 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.1 m -132.51 60.02 1.7 Allowed 'General case' 0 N--CA 1.519 3.023 0 CA-C-O 123.1 1.429 . . . . 0.0 109.951 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 8' ' ' SER . 58.6 m-85 29.38 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 34.38 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 7' ' ' THR . 16.7 p -41.78 -50.76 4.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.45 -64.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.297 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 21' ' ' GLU . 2.2 tm0? -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' NZ ' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.465 ' CD ' ' NZ ' ' A' ' 20' ' ' LYS . 4.5 mt-10 -56.5 -37.21 70.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.467 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 27.3 t80 -79.56 -45.18 19.71 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 tt -52.41 -47.59 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -63.92 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -29.03 -63.73 0.11 Allowed 'General case' 0 N--CA 1.514 2.758 0 CA-C-O 124.916 2.294 . . . . 0.0 112.98 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' N ' ' CG ' ' A' ' 25' ' ' TRP . 63.2 tp -46.88 -31.29 3.01 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 110.523 -3.035 . . . . 0.0 115.401 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.2 t 115.16 55.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 C-N-CA 130.766 3.626 . . . . 0.0 105.547 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 62.93 15.46 8.36 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 111.67 -2.514 . . . . 0.0 116.521 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 54.78 0.58 Allowed Glycine 1 N--CA 1.529 4.871 0 C-N-CA 119.957 -1.116 . . . . 0.0 115.349 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.628 ' C ' HH21 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.36 -1.305 . . . . 0.0 107.894 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.676 ' CD2' ' HG1' ' A' ' 7' ' ' THR . 20.4 m-70 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -29.87 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.34 -23.56 10.72 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.818 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.87 -71.19 0.41 Allowed Glycine 0 N--CA 1.508 3.481 0 CA-C-N 113.478 -1.692 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 1' ' ' HIS . 45.4 m -8.59 143.81 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.572 0 N-CA-C 121.149 3.759 . . . . 0.0 121.149 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.51 58.99 0.19 Allowed 'General case' 0 N--CA 1.51 2.57 0 CA-C-O 124.862 2.267 . . . . 0.0 115.434 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.676 ' HG1' ' CD2' ' A' ' 1' ' ' HIS . 0.8 OUTLIER -60.04 -46.65 88.81 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.379 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -62.06 1.89 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.413 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.88 -69.04 0.15 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 111.272 -2.695 . . . . 0.0 108.758 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -49.01 -41.89 36.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -77.12 -46.01 24.97 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 117.214 -1.374 . . . . 0.0 111.305 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -38.53 -45.77 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 123.696 1.713 . . . . 0.0 110.744 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.74 18.62 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.497 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 22.3 t90 -40.26 -57.87 1.63 Allowed 'General case' 0 N--CA 1.517 2.894 0 CA-C-O 124.223 1.963 . . . . 0.0 110.429 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 mt -53.17 -11.07 0.23 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 110.016 -3.265 . . . . 0.0 116.998 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.37 -40.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.748 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.446 ' HZ2' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -139.34 26.72 2.36 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.17 -39.73 2.65 Favored Glycine 1 N--CA 1.529 4.898 0 N-CA-C 119.527 2.571 . . . . 0.0 119.527 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.542 HH12 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 C-N-CA 126.431 1.892 . . . . 0.0 108.817 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.264 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.69 -99.42 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.82 61.64 1.14 Allowed 'General case' 0 N--CA 1.504 2.252 1 N-CA-C 98.013 -4.81 . . . . 0.0 98.013 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.37 -157.63 19.17 Favored Glycine 0 N--CA 1.506 3.322 1 N-CA-C 124.866 4.707 . . . . 0.0 124.866 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 7' ' ' THR . 54.7 m 116.0 -133.98 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 109.189 -3.505 . . . . 0.0 102.544 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' CD1' HG21 ' A' ' 10' ' ' VAL . 95.4 m-85 -80.36 37.29 0.39 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 121.855 2.116 . . . . 0.0 112.196 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 5' ' ' THR . 0.8 OUTLIER -130.25 88.8 2.7 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.692 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.0 t 74.78 -52.63 0.68 Allowed 'General case' 0 N--CA 1.514 2.744 0 CA-C-N 114.695 -1.138 . . . . 0.0 113.38 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.62 -67.81 0.25 Allowed 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.483 HG21 ' CD1' ' A' ' 6' ' ' PHE . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -44.03 -44.08 7.14 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 51.3 t80 -79.28 -47.68 15.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mt -45.7 -46.7 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-O 122.415 1.102 . . . . 0.0 108.735 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 -62.08 2.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.253 -1.794 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.434 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -29.4 -53.94 0.14 Allowed 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.568 1.652 . . . . 0.0 115.242 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.254 2.6 tt -75.17 3.95 7.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 118.857 2.91 . . . . 0.0 118.857 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t 95.37 66.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.541 1 N-CA-C 99.888 -4.115 . . . . 0.0 99.888 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.46 ' NZ ' ' OXT' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 29.76 39.6 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.55 -10.74 66.89 Favored Glycine 1 N--CA 1.526 4.691 0 N-CA-C 120.073 2.789 . . . . 0.0 120.073 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.539 ' CA ' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 128.376 2.67 . . . . 0.0 106.096 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.423 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 3.3 t60 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 116.45 -53.61 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 128.9 2.88 . . . . 0.0 104.865 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -25.11 -53.49 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.997 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -17.47 -45.76 0.01 OUTLIER Glycine 1 N--CA 1.525 4.615 0 C-N-CA 124.437 1.017 . . . . 0.0 115.181 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 3' ' ' GLU . 58.6 p -37.54 -36.57 0.17 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 8' ' ' SER . 37.3 t80 -103.73 27.51 7.43 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -12.48 -37.05 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 118.904 2.927 . . . . 0.0 118.904 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 6' ' ' PHE . 55.6 m -47.63 -33.47 6.75 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 10' ' ' VAL 0.255 1.5 p30 -46.76 -56.62 5.92 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.421 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 75.5 tt0 -50.4 -41.88 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -61.91 -46.1 90.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.8 mt -50.87 -54.19 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 117.136 -1.825 . . . . 0.0 107.785 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.19 -56.82 14.59 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.546 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.421 ' CD1' ' HG2' ' A' ' 21' ' ' GLU . 1.6 m95 -26.34 -52.87 0.05 Allowed 'General case' 0 N--CA 1.51 2.526 0 C-N-CA 125.11 1.364 . . . . 0.0 113.51 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 mp -91.59 -46.41 7.96 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 111.405 -2.634 . . . . 0.0 112.814 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -49.72 -40.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 120.27 -1.519 . . . . 0.0 110.291 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.85 62.39 6.9 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.871 0.843 . . . . 0.0 110.711 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.43 11.79 4.47 Favored Glycine 1 N--CA 1.524 4.566 0 N-CA-C 122.86 3.904 . . . . 0.0 122.86 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.561 ' C ' ' HE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 CA-C-N 119.855 1.827 . . . . 0.0 108.5 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 123.051 1.405 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.55 31.28 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -62.59 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.77 -60.53 0.42 Allowed Glycine 0 N--CA 1.513 3.8 0 N-CA-C 104.512 -3.435 . . . . 0.0 104.512 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 7' ' ' THR . 94.8 m -44.82 157.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 113.981 -1.109 . . . . 0.0 109.653 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 60.6 -18.83 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 122.662 1.22 . . . . 0.0 112.694 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.493 ' H ' ' C ' ' A' ' 5' ' ' THR . 91.2 m -91.96 71.5 5.57 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 118.821 -2.424 . . . . 0.0 110.704 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' THR . 28.0 t 127.28 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 8' ' ' SER 0.272 6.1 t0 -14.91 -71.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 125.805 1.941 . . . . 0.0 111.165 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -41.16 -44.33 2.53 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' ILE . 13.7 m-85 -74.65 -46.89 35.12 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -44.78 -45.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.5 -58.68 4.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -35.96 -50.03 0.66 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 124.007 1.861 . . . . 0.0 111.887 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.9 mt -76.97 50.95 0.76 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.431 -2.622 . . . . 0.0 112.98 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t 42.44 49.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 124.626 2.155 . . . . 0.0 108.256 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' CB ' ' HZ3' ' A' ' 28' ' ' LYS . 6.3 mtpm? 55.01 60.67 3.33 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.553 -2.567 . . . . 0.0 117.438 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.06 -14.79 5.92 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 122.923 3.929 . . . . 0.0 122.923 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.445 ' HB2' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.58 0 CA-C-N 120.807 2.303 . . . . 0.0 110.032 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 2' ' ' ALA . 54.6 t-80 . . . . . 0 N--CA 1.507 2.4 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.432 ' N ' ' ND1' ' A' ' 1' ' ' HIS . . . -139.22 -89.92 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.21 1.569 . . . . 0.0 106.791 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -112.82 -21.45 11.17 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.291 1.436 . . . . 0.0 112.821 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.91 -30.55 3.91 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.019 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.8 m -145.11 49.08 1.27 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -47.05 150.01 0.84 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.0 t -133.99 -57.62 0.86 Allowed 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 p -45.48 -37.51 5.32 Favored 'General case' 0 N--CA 1.521 3.102 0 CA-C-O 122.75 1.262 . . . . 0.0 111.355 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -73.24 -68.78 0.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.458 HE21 ' CG ' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.458 ' CG ' HE21 ' A' ' 17' ' ' GLN . 0.6 OUTLIER -60.9 -19.82 61.04 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -77.23 -52.31 9.45 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.3 mt -48.26 -45.26 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 124.086 1.898 . . . . 0.0 107.006 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.48 60.42 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.472 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.408 ' N ' ' O ' ' A' ' 21' ' ' GLU . 26.0 t90 -43.25 -48.57 6.68 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-O 122.332 1.063 . . . . 0.0 108.745 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -58.98 -59.63 5.16 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -45.59 -23.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 CA-C-N 114.2 -1.363 . . . . 0.0 113.15 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.69 -28.06 53.59 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.69 -0.631 . . . . 0.0 110.775 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.21 -37.62 9.75 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.546 ' NH2' ' C ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 C-N-CA 130.027 3.331 . . . . 0.0 116.551 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' GLY . 34.8 m170 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.87 -42.63 4.65 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-O 123.502 1.62 . . . . 0.0 111.117 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.602 ' CD ' ' HG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -89.04 -18.54 27.12 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 111.665 -2.516 . . . . 0.0 112.717 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 1' ' ' HIS . . . 148.84 -148.85 20.65 Favored Glycine 1 N--CA 1.517 4.099 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -109.7 164.25 12.73 Favored 'General case' 0 N--CA 1.524 3.266 0 O-C-N 122.455 -0.438 . . . . 0.0 111.943 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.443 ' CD1' HG21 ' A' ' 10' ' ' VAL . 13.8 t80 63.47 33.18 13.82 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-O 123.551 1.644 . . . . 0.0 109.931 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.602 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 73.2 p -121.15 -64.86 1.19 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 121.187 -0.946 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' N ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.06 -25.75 16.33 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 -69.37 -176.23 0.93 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 6' ' ' PHE . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' THR . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 13' ' ' TYR . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.418 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -41.11 -32.5 0.26 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 23' ' ' ILE . 46.8 t80 -91.54 -51.0 5.48 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.815 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -45.28 -43.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 CA-C-N 120.984 1.72 . . . . 0.0 107.906 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.81 -52.36 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.432 ' O ' ' NH1' ' A' ' 30' ' ' ARG . 25.4 t90 -47.91 -28.08 2.49 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.447 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.1 mm? -93.43 -21.05 19.74 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.92 -31.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -139.08 29.15 2.27 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.695 1.236 . . . . 0.0 110.388 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.15 9.01 5.11 Favored Glycine 0 N--CA 1.512 3.756 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.744 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.616 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 O-C-N 125.862 1.566 . . . . 0.0 109.242 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.57 ' CG ' ' HB ' ' A' ' 7' ' ' THR . 13.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 116.12 -1.895 . . . . 0.0 106.299 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 82.71 23.75 0.17 Allowed 'General case' 0 N--CA 1.527 3.421 0 O-C-N 125.357 1.661 . . . . 0.0 112.135 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -122.5 -44.91 2.22 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.445 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.85 -52.19 0.32 Allowed Glycine 0 N--CA 1.515 3.962 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 7' ' ' THR . 50.9 m -149.64 166.41 29.39 Favored 'General case' 0 N--CA 1.524 3.229 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -31.72 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 118.932 2.938 . . . . 0.0 118.932 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.57 ' HB ' ' CG ' ' A' ' 1' ' ' HIS . 36.2 p -119.36 -24.92 6.21 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-O 122.878 1.323 . . . . 0.0 111.282 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.4 t -124.98 -58.62 1.46 Allowed 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 124.983 2.325 . . . . 0.0 105.267 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -25.24 -54.61 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 109.065 -3.698 . . . . 0.0 109.116 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 3.8 tp10 -57.46 -37.15 72.41 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -64.96 -45.14 86.99 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.62 -55.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.58 -40.42 52.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.828 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CZ2' ' NE ' ' A' ' 30' ' ' ARG . 3.4 t90 -43.34 -29.46 0.42 Allowed 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 124.209 1.003 . . . . 0.0 113.684 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -99.27 15.11 27.2 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 123.778 1.752 . . . . 0.0 115.686 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.99 -42.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-O 124.896 2.284 . . . . 0.0 106.365 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 5.9 ttpt -111.33 68.56 0.67 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.463 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.3 -73.66 0.29 Allowed Glycine 1 N--CA 1.525 4.582 0 N-CA-C 122.494 3.758 . . . . 0.0 122.494 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.566 HH12 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.581 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.21 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 125.815 1.646 . . . . 0.0 107.334 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -92.42 -64.4 1.11 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 111.65 -2.523 . . . . 0.0 111.479 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.506 ' H ' ' CG ' ' A' ' 3' ' ' GLU . . . -155.35 -69.27 0.01 OUTLIER Glycine 0 N--CA 1.512 3.762 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -114.52 -79.75 0.59 Allowed 'General case' 0 N--CA 1.508 2.475 0 CA-C-N 112.564 -1.818 . . . . 0.0 108.756 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.16 116.71 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -32.09 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -89.41 -14.65 35.01 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -49.22 -43.83 42.82 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.502 ' HB3' ' CG ' ' A' ' 21' ' ' GLU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.502 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 -54.29 -36.92 64.2 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 25' ' ' TRP . 13.6 t80 -73.55 -46.24 48.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.415 ' O ' HD21 ' A' ' 26' ' ' LEU . 95.8 mt -57.11 -49.34 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.543 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.48 -24.59 42.22 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 123.899 1.809 . . . . 0.0 109.384 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . 2.3 t90 -27.65 -58.15 0.11 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 30' ' ' ARG 0.269 0.4 OUTLIER -47.58 -13.99 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 -179.244 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.3 t -99.62 -28.1 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 13.7 ptmt -121.97 52.96 1.23 Allowed 'General case' 0 CA--C 1.582 2.176 0 CA-C-N 112.246 -2.252 . . . . 0.0 114.466 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.97 -66.77 0.42 Allowed Glycine 1 N--CA 1.534 5.178 1 N-CA-C 127.023 5.569 . . . . 0.0 127.023 179.61 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.608 HH11 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.526 3.337 0 CA-C-N 121.915 2.858 . . . . 0.0 117.186 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 6' ' ' PHE . 16.9 m-70 . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.78 -42.18 7.56 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 124.571 2.129 . . . . 0.0 112.104 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.645 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -90.35 17.05 7.66 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 109.928 -3.306 . . . . 0.0 114.598 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.17 -64.38 0.26 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 114.773 -1.103 . . . . 0.0 115.159 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -124.23 -72.82 0.66 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' HIS . 48.5 m-85 -1.48 135.14 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 p -132.6 -79.16 0.5 Allowed 'General case' 0 N--CA 1.522 3.158 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 p -40.79 -36.96 0.69 Allowed 'General case' 0 N--CA 1.526 3.353 0 CA-C-O 124.735 2.207 . . . . 0.0 110.907 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -34.9 -53.42 0.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 109.774 -3.376 . . . . 0.0 109.226 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 13' ' ' TYR . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' GLY . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -102.04 -30.3 11.27 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.6 -42.35 83.05 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -47.42 -40.57 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.446 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.15 -35.52 21.66 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.06 -1.882 . . . . 0.0 108.493 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' CD1' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -52.78 -49.06 66.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.844 -1.785 . . . . 0.0 106.824 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.8 mp -79.21 17.85 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -121.83 -48.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.518 ' NZ ' ' CD1' ' A' ' 25' ' ' TRP . 58.1 mttt -19.12 -38.33 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -129.72 13.16 5.87 Favored Glycine 1 N--CA 1.523 4.487 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.615 ' NH2' ' HB2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.528 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.1 m80 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.08 -46.87 6.31 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 121.956 2.162 . . . . 0.0 106.92 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -91.2 -47.38 7.55 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.054 -2.339 . . . . 0.0 109.204 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.55 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -97.72 85.98 0.79 Allowed Glycine 0 N--CA 1.509 3.564 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.018 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -132.27 170.06 15.59 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.179 -1.011 . . . . 0.0 108.389 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -64.55 55.05 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 119.089 2.996 . . . . 0.0 119.089 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -142.26 -63.42 0.43 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -69.41 -58.55 3.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 111.637 -2.529 . . . . 0.0 107.491 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.18 -55.18 16.2 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.468 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 -48.09 -34.38 9.59 Favored 'General case' 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -81.05 -38.44 27.4 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' C ' ' H ' ' A' ' 25' ' ' TRP . 2.5 tp -56.27 -43.79 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.69 24.41 0.06 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.97 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.525 ' H ' ' C ' ' A' ' 23' ' ' ILE . 67.4 t90 -127.28 -62.38 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 102.695 -3.076 . . . . 0.0 102.695 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -58.9 -31.65 68.82 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 111.42 -2.627 . . . . 0.0 113.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.46 -35.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.062 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.408 ' HE2' ' O ' ' A' ' 28' ' ' LYS . 3.5 ttpt -113.81 20.24 16.0 Favored 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.84 -9.16 5.87 Favored Glycine 1 N--CA 1.527 4.755 0 O-C-N 121.781 -0.574 . . . . 0.0 113.167 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.419 ' H ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.176 0 O-C-N 126.029 1.664 . . . . 0.0 111.189 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.571 ' CD2' ' H ' ' A' ' 2' ' ' ALA . 15.9 t-160 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 116.705 -1.617 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' H ' ' CD2' ' A' ' 1' ' ' HIS . . . 38.14 32.18 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.763 0 CA-C-O 124.176 1.941 . . . . 0.0 107.944 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' H ' ' CD ' ' A' ' 3' ' ' GLU 0.258 0.0 OUTLIER 4.64 61.73 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 110.248 -3.16 . . . . 0.0 112.889 -178.906 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 15.26 46.24 0.01 OUTLIER Glycine 1 N--CA 1.522 4.382 1 CA-C-N 106.164 -5.016 . . . . 0.0 117.113 -179.979 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' GLY . 82.6 m 104.22 48.49 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.625 0 O-C-N 126.145 1.732 . . . . 0.0 114.257 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -55.06 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.2 t -89.87 -158.5 0.53 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -9.89 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 120.825 3.639 . . . . 0.0 120.825 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER -89.18 -82.1 0.26 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 127.373 2.269 . . . . 0.0 108.89 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' CD ' ' HZ2' ' A' ' 20' ' ' LYS . 17.2 mp0 -50.1 -48.17 53.47 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HA ' ' CD2' ' A' ' 25' ' ' TRP . 33.5 t80 -64.7 -44.66 89.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.299 1.047 . . . . 0.0 108.295 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.6 mt -52.26 -54.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.65 -58.6 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 45.5 m0 -32.11 -56.54 0.31 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 11.1 mp -90.37 -30.03 17.68 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.91 -53.15 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 121.953 -0.467 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 4.9 tptp -122.65 -8.19 8.51 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.86 -28.04 46.19 Favored Glycine 1 N--CA 1.529 4.89 0 N-CA-C 106.08 -2.808 . . . . 0.0 106.08 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.631 0 CA-C-N 109.655 -3.273 . . . . 0.0 103.11 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.423 0.63 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 120.317 0.103 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' GLU . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 . . . . . 0 N--CA 1.477 0.877 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 . . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' ' 14' ' ' LEU . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.436 0.636 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 . . . . . 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.0 0.428 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.653 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.653 ' HZ1' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.426 1.1 t0 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 14' ' ' LEU . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 4.7 pt-20 . . . . . 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.613 0.721 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 12' ' ' SER . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' HE3' ' A' ' 20' ' ' LYS . 31.9 mt-10 . . . . . 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 14' ' ' LEU . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 4.5 mt-10 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 12' ' ' SER 0.255 1.5 p30 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 20' ' ' LYS . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.272 6.1 t0 . . . . . 0 N--CA 1.505 2.321 0 CA-C-O 122.641 1.21 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.494 ' NE2' ' HG2' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' NE2' ' A' ' 17' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 . . . . . 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 124.128 1.918 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.88 1.324 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 14' ' ' LEU . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HA ' ' H ' ' A' ' 19' ' ' ALA . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' GLU . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 . . . . . 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 17.2 mp0 . . . . . 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 31.8 t60 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 114.628 -2.606 . . . . 0.0 106.053 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 109.57 73.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.251 0.5 OUTLIER -1.28 86.62 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.825 1 CA-C-O 128.655 4.074 . . . . 0.0 117.568 -179.557 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 6' ' ' PHE . . . 140.11 -77.82 0.31 Allowed Glycine 0 N--CA 1.495 2.607 2 N-CA-C 97.75 -6.14 . . . . 0.0 97.75 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 50.4 m -20.51 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 126.456 1.903 . . . . 0.0 116.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 8' ' ' SER . 7.3 t80 77.04 -65.65 0.28 Allowed 'General case' 0 N--CA 1.511 2.585 0 C-N-CA 126.472 1.909 . . . . 0.0 109.068 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -14.89 -48.32 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.809 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' PHE . 32.7 t -36.52 -55.61 0.84 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 113.857 -1.519 . . . . 0.0 112.874 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 -49.85 -80.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.396 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 28' ' ' LYS . 10.1 tp10 -34.79 -55.9 0.56 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -83.25 -45.43 13.84 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.836 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -41.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-O 123.199 1.476 . . . . 0.0 110.402 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.2 -36.71 14.62 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.585 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -31.22 -58.47 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 CA-C-O 123.162 1.458 . . . . 0.0 113.96 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 26' ' ' LEU . 34.1 mt -43.29 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' GLY . 87.6 t -117.09 -50.89 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 2.8 tmmt? -83.22 48.0 1.32 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 124.472 2.082 . . . . 0.0 106.842 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . -133.26 -15.62 1.28 Allowed Glycine 0 N--CA 1.503 3.138 0 CA-C-N 111.407 -2.633 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.173 0 O-C-N 126.384 1.873 . . . . 0.0 108.723 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 115.658 -2.115 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.44 -71.07 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 120.996 1.726 . . . . 0.0 113.867 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -101.05 -65.15 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.18 89.69 0.21 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 6' ' ' PHE . 12.7 t 126.5 -158.56 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 130.6 3.56 . . . . 0.0 105.438 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 5' ' ' THR . 5.9 p90 -23.26 71.27 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.4 m 165.41 -70.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 128.923 2.889 . . . . 0.0 105.231 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -56.24 -59.43 4.95 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.389 -0.82 . . . . 0.0 109.589 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -48.12 -51.8 23.19 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' GLU . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -51.05 -21.93 2.11 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 68.0 t80 -95.51 -57.51 2.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.41 -38.6 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 122.937 1.351 . . . . 0.0 110.814 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.39 36.93 1.05 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 122.493 1.14 . . . . 0.0 109.358 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 22' ' ' PHE . 27.5 t90 -114.14 -83.59 0.61 Allowed 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 122.95 1.357 . . . . 0.0 109.936 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 1.1 pt? -51.12 -9.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.83 15.84 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.083 0 CA-C-O 123.548 1.642 . . . . 0.0 110.486 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.69 -48.58 0.25 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.185 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.67 53.03 0.83 Allowed Glycine 0 N--CA 1.513 3.804 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.782 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.507 2.399 0 CA-C-O 115.281 -2.295 . . . . 0.0 110.668 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.9 p80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 -55.13 1.15 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 101.666 -3.457 . . . . 0.0 101.666 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.74 50.61 2.03 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 111.557 -2.565 . . . . 0.0 107.143 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 7' ' ' THR . . . 8.98 -98.7 0.01 OUTLIER Glycine 1 N--CA 1.527 4.713 0 CA-C-N 113.289 -1.778 . . . . 0.0 116.255 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -39.46 -27.14 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 12.1 m-85 -107.89 -5.5 17.17 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 125.037 2.351 . . . . 0.0 114.338 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.525 ' HA ' ' OE2' ' A' ' 3' ' ' GLU . 7.3 t 10.2 26.16 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.251 1 N-CA-C 126.621 5.786 . . . . 0.0 126.621 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t 76.54 16.48 2.01 Favored 'General case' 0 N--CA 1.535 3.793 0 CA-C-O 124.596 2.141 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 -125.68 -91.41 0.53 Allowed 'General case' 0 C--N 1.29 -1.995 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 -179.998 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 6' ' ' PHE . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 53.3 mm-40 -44.98 -62.48 1.22 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.94 38.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 124.802 2.239 . . . . 0.0 112.007 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -127.07 -47.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -73.04 -53.51 10.95 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.568 -2.105 . . . . 0.0 112.019 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 44.6 m0 -23.66 -55.01 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 123.435 1.588 . . . . 0.0 114.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 30' ' ' ARG . 4.4 mm? -100.84 73.62 1.58 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 112.6 -2.091 . . . . 0.0 112.658 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 m 45.32 28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 110.658 -2.974 . . . . 0.0 113.84 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.619 ' HB2' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 73.05 43.45 0.4 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.39 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.25 -49.36 0.08 OUTLIER Glycine 0 N--CA 1.505 3.257 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.568 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.658 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.581 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.53 ' CG ' ' HB3' ' A' ' 6' ' ' PHE . 54.2 m170 . . . . . 0 N--CA 1.507 2.383 0 CA-C-O 116.569 -1.682 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -39.69 151.72 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.935 1.243 . . . . 0.0 110.595 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 36.18 25.68 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 CA-C-O 124.894 2.283 . . . . 0.0 115.651 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.5 -68.63 0.42 Allowed Glycine 0 N--CA 1.512 3.738 0 O-C-N 119.601 -1.937 . . . . 0.0 112.483 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 p 20.6 -101.28 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.419 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.53 ' HB3' ' CG ' ' A' ' 1' ' ' HIS . 62.1 t80 -69.55 108.07 3.66 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.382 -1.449 . . . . 0.0 108.655 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t 173.51 -38.08 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 111.153 -2.749 . . . . 0.0 105.752 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -26.02 -55.14 0.06 Allowed 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 112.92 -1.945 . . . . 0.0 115.624 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 -60.18 -86.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.095 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 19.2 tp10 -48.99 -53.09 21.4 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HA ' ' CG ' ' A' ' 25' ' ' TRP . 15.7 t80 -63.41 -46.73 85.04 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 123.628 1.68 . . . . 0.0 106.717 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.58 -14.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.442 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.15 -35.41 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.299 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 41.7 m0 -28.6 -66.85 0.08 Allowed 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -43.45 -18.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 111.448 -2.614 . . . . 0.0 115.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -114.49 -44.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 61.6 mtpt -51.44 -46.08 62.89 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.768 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 30' ' ' ARG . . . -141.11 -30.16 0.17 Allowed Glycine 0 N--CA 1.513 3.775 0 CA-C-N 113.765 -1.561 . . . . 0.0 115.127 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.581 ' HB3' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.536 0 C-N-CA 129.282 3.033 . . . . 0.0 105.932 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 . . . . . 0 N--CA 1.506 2.368 0 CA-C-O 122.699 1.238 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -137.81 -53.46 0.65 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 6.5 mp0 -5.54 -60.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 112.079 -2.328 . . . . 0.0 116.606 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.91 55.56 4.91 Favored Glycine 0 N--CA 1.51 3.623 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.353 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 m 66.4 -33.12 0.19 Allowed 'General case' 0 N--CA 1.528 3.447 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 7' ' ' THR . 9.1 t80 40.78 -102.35 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.413 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.489 ' N ' ' CG ' ' A' ' 6' ' ' PHE . 57.0 p 4.11 -75.85 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.792 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.5 m -32.43 -42.42 0.07 Allowed 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -28.36 -49.61 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.008 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -48.23 2.97 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.8 t80 -54.03 -44.4 70.95 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 24' ' ' ALA . 8.4 tp -43.33 -49.41 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 112.024 -2.353 . . . . 0.0 110.5 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' N ' HG23 ' A' ' 23' ' ' ILE . . . -62.77 -47.48 83.32 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.194 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 1.5 t90 -46.96 -36.04 7.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.438 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 82.6 mt -107.8 33.58 4.0 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 124.389 2.043 . . . . 0.0 114.917 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.4 t -130.13 -50.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.077 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 25' ' ' TRP . 4.6 pttt -19.79 -53.35 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.21 44.61 1.15 Allowed Glycine 0 N--CA 1.515 3.962 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.623 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.458 HH21 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.162 0 O-C-N 125.449 1.323 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 122.499 1.143 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.559 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -150.01 -65.04 0.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -33.89 -48.96 0.32 Allowed 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.371 179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -26.93 -39.26 0.01 OUTLIER Glycine 0 N--CA 1.516 3.985 0 N-CA-C 117.91 1.924 . . . . 0.0 117.91 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 7' ' ' THR . 67.5 p -106.35 19.95 19.72 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 8' ' ' SER . 36.2 p90 6.64 -54.63 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 121.512 3.893 . . . . 0.0 121.512 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 8' ' ' SER . 1.3 t 38.17 -65.02 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.546 ' H ' HG23 ' A' ' 7' ' ' THR . 12.0 m -91.43 -36.85 13.54 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -50.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.653 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.653 ' HZ1' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.35 -41.99 90.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.85 -46.32 88.45 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -52.08 -52.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 117.841 -1.543 . . . . 0.0 108.388 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.5 -50.65 9.38 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.142 -0.974 . . . . 0.0 110.676 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -30.55 -54.13 0.19 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 124.427 2.06 . . . . 0.0 113.341 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 ' H ' HD13 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.17 -23.91 13.22 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.603 -2.999 . . . . 0.0 118.278 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.546 ' N ' HD22 ' A' ' 26' ' ' LEU . 21.1 m -82.08 -27.51 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 CA-C-N 120.758 1.617 . . . . 0.0 108.275 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -131.36 -24.18 2.31 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 118.334 2.716 . . . . 0.0 118.334 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.53 50.65 0.79 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.561 1.163 . . . . 0.0 114.994 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.755 ' CZ ' ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.503 ' N ' ' OG1' ' A' ' 5' ' ' THR . 2.2 m-70 . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.481 ' HB1' ' CE2' ' A' ' 6' ' ' PHE . . . 110.89 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 127.649 2.38 . . . . 0.0 104.971 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -89.8 58.48 4.26 Favored 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -128.97 6.48 Favored Glycine 0 N--CA 1.51 3.578 0 N-CA-C 105.092 -3.203 . . . . 0.0 105.092 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.528 ' C ' ' HB3' ' A' ' 9' ' ' ASP . 30.9 m -142.96 48.66 1.49 Allowed 'General case' 0 N--CA 1.525 3.304 0 O-C-N 120.745 -1.444 . . . . 0.0 112.543 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 10.5 m-30 -12.75 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -33.16 -48.43 0.22 Allowed 'General case' 0 N--CA 1.528 3.445 0 CA-C-O 122.862 1.315 . . . . 0.0 113.815 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -106.96 -44.64 4.36 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 112.425 -2.17 . . . . 0.0 108.959 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' HB3' ' C ' ' A' ' 5' ' ' THR 0.426 1.1 t0 -47.91 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.705 -2.043 . . . . 0.0 107.374 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 14' ' ' LEU . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 4.7 pt-20 -102.46 -41.53 6.27 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.9 t80 -57.95 -39.9 79.23 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.7 mt -52.44 -44.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.025 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.34 -58.26 8.47 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.634 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -31.0 -49.99 0.14 Allowed 'General case' 0 N--CA 1.521 3.123 0 CA-C-O 125.093 2.377 . . . . 0.0 113.404 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.304 62.4 tp -100.3 -16.39 17.7 Favored 'General case' 0 C--N 1.288 -2.083 1 CA-C-N 108.117 -4.129 . . . . 0.0 120.687 -178.97 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.9 t -84.86 -31.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.226 -0.921 . . . . 0.0 110.498 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' NZ ' ' OXT' ' A' ' 30' ' ' ARG . 0.4 OUTLIER 139.86 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.583 1.953 . . . . 0.0 111.73 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . 81.6 -40.43 2.6 Favored Glycine 1 N--CA 1.523 4.462 0 C-N-CA 119.64 -1.267 . . . . 0.0 115.752 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.593 ' NH1' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 C-N-CA 126.24 1.816 . . . . 0.0 107.716 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.663 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 13.1 t-80 . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' H ' ' CG ' ' A' ' 1' ' ' HIS . . . -29.77 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-N 123.907 3.049 . . . . 0.0 117.289 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -84.02 -5.13 59.17 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 118.945 2.942 . . . . 0.0 118.945 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 17.64 46.45 0.01 OUTLIER Glycine 1 N--CA 1.524 4.53 0 N-CA-C 117.544 1.778 . . . . 0.0 117.544 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -127.75 -156.39 0.75 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 8' ' ' SER . 67.9 m-85 67.29 -71.93 0.1 Allowed 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.591 1.156 . . . . 0.0 111.427 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p 41.24 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' PHE . 65.1 m -35.36 -38.46 0.1 Allowed 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 126.92 2.088 . . . . 0.0 115.326 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 -95.11 -65.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.415 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 12' ' ' SER . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' HE3' ' A' ' 20' ' ' LYS . 31.9 mt-10 -62.47 -36.94 84.06 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.3 t80 -65.12 -44.0 90.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.1 mt -53.4 -47.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.13 -49.88 40.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -50.92 -67.72 0.23 Allowed 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 124.95 2.309 . . . . 0.0 107.769 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.297 4.2 tt -31.23 -40.38 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 108.892 -3.776 . . . . 0.0 113.003 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -100.87 -41.86 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -122.62 17.04 10.38 Favored 'General case' 0 N--CA 1.521 3.091 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.48 -54.14 0.15 Allowed Glycine 1 N--CA 1.525 4.575 0 N-CA-C 106.194 -2.763 . . . . 0.0 106.194 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.727 ' CZ ' ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.57 1 C-N-CA 131.989 4.115 . . . . 0.0 111.643 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 58.7 t-80 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.472 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -66.3 170.85 5.38 Favored 'General case' 0 CA--C 1.588 2.422 1 N-CA-C 98.651 -4.574 . . . . 0.0 98.651 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 26.33 12.51 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 121.217 3.784 . . . . 0.0 121.217 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . -155.5 76.63 0.21 Allowed Glycine 0 N--CA 1.509 3.511 0 O-C-N 119.842 -1.786 . . . . 0.0 113.459 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.1 m -132.51 60.02 1.7 Allowed 'General case' 0 N--CA 1.519 3.023 0 CA-C-O 123.1 1.429 . . . . 0.0 109.951 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 8' ' ' SER . 58.6 m-85 29.38 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 34.38 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.565 ' H ' HG23 ' A' ' 7' ' ' THR . 16.7 p -41.78 -50.76 4.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.45 -64.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.297 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 14' ' ' LEU . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 4.5 mt-10 -56.5 -37.21 70.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 27.3 t80 -79.56 -45.18 19.71 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 tt -52.41 -47.59 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -63.92 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -29.03 -63.73 0.11 Allowed 'General case' 0 N--CA 1.514 2.758 0 CA-C-O 124.916 2.294 . . . . 0.0 112.98 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' N ' ' CG ' ' A' ' 25' ' ' TRP . 63.2 tp -46.88 -31.29 3.01 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 110.523 -3.035 . . . . 0.0 115.401 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HB ' ' NH1' ' A' ' 30' ' ' ARG . 93.2 t 115.16 55.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 C-N-CA 130.766 3.626 . . . . 0.0 105.547 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 62.93 15.46 8.36 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 111.67 -2.514 . . . . 0.0 116.521 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 54.78 0.58 Allowed Glycine 1 N--CA 1.529 4.871 0 C-N-CA 119.957 -1.116 . . . . 0.0 115.349 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.637 HH21 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.36 -1.305 . . . . 0.0 107.894 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' THR . 23.6 m170 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -29.87 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -111.34 -23.56 10.72 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.818 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.87 -71.19 0.41 Allowed Glycine 0 N--CA 1.508 3.481 0 CA-C-N 113.478 -1.692 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 1' ' ' HIS . 45.4 m -8.59 143.81 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.572 0 N-CA-C 121.149 3.759 . . . . 0.0 121.149 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.51 58.99 0.19 Allowed 'General case' 0 N--CA 1.51 2.57 0 CA-C-O 124.862 2.267 . . . . 0.0 115.434 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -46.65 88.81 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -62.06 1.89 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.413 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.88 -69.04 0.15 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 111.272 -2.695 . . . . 0.0 108.758 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -49.01 -41.89 36.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 25' ' ' TRP . 33.2 m-85 -77.12 -46.01 24.97 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 117.214 -1.374 . . . . 0.0 111.305 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -38.53 -45.77 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 123.696 1.713 . . . . 0.0 110.744 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.74 18.62 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.497 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CB ' ' HA ' ' A' ' 22' ' ' PHE . 22.3 t90 -40.26 -57.87 1.63 Allowed 'General case' 0 N--CA 1.517 2.894 0 CA-C-O 124.223 1.963 . . . . 0.0 110.429 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 mt -53.17 -11.07 0.23 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 110.016 -3.265 . . . . 0.0 116.998 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.37 -40.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.748 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -139.34 26.72 2.36 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.17 -39.73 2.65 Favored Glycine 1 N--CA 1.529 4.898 0 N-CA-C 119.527 2.571 . . . . 0.0 119.527 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.498 ' C ' HH12 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 C-N-CA 126.431 1.892 . . . . 0.0 108.817 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.69 -99.42 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.82 61.64 1.14 Allowed 'General case' 0 N--CA 1.504 2.252 1 N-CA-C 98.013 -4.81 . . . . 0.0 98.013 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.37 -157.63 19.17 Favored Glycine 0 N--CA 1.506 3.322 1 N-CA-C 124.866 4.707 . . . . 0.0 124.866 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 7' ' ' THR . 54.7 m 116.0 -133.98 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 109.189 -3.505 . . . . 0.0 102.544 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 10' ' ' VAL . 95.4 m-85 -80.36 37.29 0.39 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 121.855 2.116 . . . . 0.0 112.196 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' THR . 0.8 OUTLIER -130.25 88.8 2.7 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.692 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.0 t 74.78 -52.63 0.68 Allowed 'General case' 0 N--CA 1.514 2.744 0 CA-C-N 114.695 -1.138 . . . . 0.0 113.38 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 1' ' ' HIS . 0.7 OUTLIER -45.62 -67.81 0.25 Allowed 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 6' ' ' PHE . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -44.03 -44.08 7.14 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 51.3 t80 -79.28 -47.68 15.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mt -45.7 -46.7 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-O 122.415 1.102 . . . . 0.0 108.735 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 -62.08 2.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.253 -1.794 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -29.4 -53.94 0.14 Allowed 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.568 1.652 . . . . 0.0 115.242 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.254 2.6 tt -75.17 3.95 7.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 118.857 2.91 . . . . 0.0 118.857 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t 95.37 66.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.541 1 N-CA-C 99.888 -4.115 . . . . 0.0 99.888 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' NZ ' ' OXT' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 29.76 39.6 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.55 -10.74 66.89 Favored Glycine 1 N--CA 1.526 4.691 0 N-CA-C 120.073 2.789 . . . . 0.0 120.073 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' NH1' ' HA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 128.376 2.67 . . . . 0.0 106.096 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.423 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 3.3 t60 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 116.45 -53.61 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 128.9 2.88 . . . . 0.0 104.865 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -25.11 -53.49 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.997 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -17.47 -45.76 0.01 OUTLIER Glycine 1 N--CA 1.525 4.615 0 C-N-CA 124.437 1.017 . . . . 0.0 115.181 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 3' ' ' GLU . 58.6 p -37.54 -36.57 0.17 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 8' ' ' SER . 37.3 t80 -103.73 27.51 7.43 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -12.48 -37.05 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 118.904 2.927 . . . . 0.0 118.904 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 6' ' ' PHE . 55.6 m -47.63 -33.47 6.75 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 12' ' ' SER 0.255 1.5 p30 -46.76 -56.62 5.92 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' N ' HD12 ' A' ' 14' ' ' LEU . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 20' ' ' LYS . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 75.5 tt0 -50.4 -41.88 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 56.9 t80 -61.91 -46.1 90.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.8 mt -50.87 -54.19 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 117.136 -1.825 . . . . 0.0 107.785 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.19 -56.82 14.59 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.546 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 21' ' ' GLU . 1.6 m95 -26.34 -52.87 0.05 Allowed 'General case' 0 N--CA 1.51 2.526 0 C-N-CA 125.11 1.364 . . . . 0.0 113.51 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 25' ' ' TRP . 4.9 mp -91.59 -46.41 7.96 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 111.405 -2.634 . . . . 0.0 112.814 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -49.72 -40.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 120.27 -1.519 . . . . 0.0 110.291 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.85 62.39 6.9 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.871 0.843 . . . . 0.0 110.711 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.43 11.79 4.47 Favored Glycine 1 N--CA 1.524 4.566 0 N-CA-C 122.86 3.904 . . . . 0.0 122.86 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.541 ' HE ' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 CA-C-N 119.855 1.827 . . . . 0.0 108.5 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.52 ' HA ' HG21 ' A' ' 7' ' ' THR . 41.6 m-70 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 123.051 1.405 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.55 31.28 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -62.59 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.77 -60.53 0.42 Allowed Glycine 0 N--CA 1.513 3.8 0 N-CA-C 104.512 -3.435 . . . . 0.0 104.512 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 7' ' ' THR . 94.8 m -44.82 157.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 113.981 -1.109 . . . . 0.0 109.653 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 60.6 -18.83 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 122.662 1.22 . . . . 0.0 112.694 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.52 HG21 ' HA ' ' A' ' 1' ' ' HIS . 91.2 m -91.96 71.5 5.57 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 118.821 -2.424 . . . . 0.0 110.704 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' THR . 28.0 t 127.28 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 8' ' ' SER 0.272 6.1 t0 -14.91 -71.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 125.805 1.941 . . . . 0.0 111.165 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -41.16 -44.33 2.53 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' ILE . 13.7 m-85 -74.65 -46.89 35.12 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -44.78 -45.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.5 -58.68 4.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -35.96 -50.03 0.66 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 124.007 1.861 . . . . 0.0 111.887 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.9 mt -76.97 50.95 0.76 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.431 -2.622 . . . . 0.0 112.98 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t 42.44 49.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 124.626 2.155 . . . . 0.0 108.256 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 6.3 mtpm? 55.01 60.67 3.33 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.553 -2.567 . . . . 0.0 117.438 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.06 -14.79 5.92 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 122.923 3.929 . . . . 0.0 122.923 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.577 ' HB2' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.58 0 CA-C-N 120.807 2.303 . . . . 0.0 110.032 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 2' ' ' ALA . 54.6 t-80 . . . . . 0 N--CA 1.507 2.4 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.432 ' N ' ' ND1' ' A' ' 1' ' ' HIS . . . -139.22 -89.92 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.21 1.569 . . . . 0.0 106.791 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -112.82 -21.45 11.17 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.291 1.436 . . . . 0.0 112.821 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.91 -30.55 3.91 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.019 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 69.8 m -145.11 49.08 1.27 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -47.05 150.01 0.84 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 8' ' ' SER . 2.0 t -133.99 -57.62 0.86 Allowed 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 7' ' ' THR . 39.5 p -45.48 -37.51 5.32 Favored 'General case' 0 N--CA 1.521 3.102 0 CA-C-O 122.75 1.262 . . . . 0.0 111.355 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -73.24 -68.78 0.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.494 ' NE2' ' HG2' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' NE2' ' A' ' 17' ' ' GLN . 0.6 OUTLIER -60.9 -19.82 61.04 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -77.23 -52.31 9.45 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.3 mt -48.26 -45.26 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 124.086 1.898 . . . . 0.0 107.006 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.48 60.42 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.472 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.407 ' N ' ' O ' ' A' ' 21' ' ' GLU . 26.0 t90 -43.25 -48.57 6.68 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-O 122.332 1.063 . . . . 0.0 108.745 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.6 mm? -58.98 -59.63 5.16 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -45.59 -23.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 CA-C-N 114.2 -1.363 . . . . 0.0 113.15 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.69 -28.06 53.59 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.69 -0.631 . . . . 0.0 110.775 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.21 -37.62 9.75 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.546 ' C ' ' NH2' ' A' ' 30' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 C-N-CA 130.027 3.331 . . . . 0.0 116.551 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' GLY . 34.8 m170 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.87 -42.63 4.65 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-O 123.502 1.62 . . . . 0.0 111.117 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -89.04 -18.54 27.12 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 111.665 -2.516 . . . . 0.0 112.717 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 1' ' ' HIS . . . 148.84 -148.85 20.65 Favored Glycine 1 N--CA 1.517 4.099 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -109.7 164.25 12.73 Favored 'General case' 0 N--CA 1.524 3.266 0 O-C-N 122.455 -0.438 . . . . 0.0 111.943 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 13.8 t80 63.47 33.18 13.82 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-O 123.551 1.644 . . . . 0.0 109.931 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 3' ' ' GLU . 73.2 p -121.15 -64.86 1.19 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 121.187 -0.946 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' N ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.06 -25.75 16.33 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 -69.37 -176.23 0.93 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 6' ' ' PHE . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -41.11 -32.5 0.26 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 23' ' ' ILE . 46.8 t80 -91.54 -51.0 5.48 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.815 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -45.28 -43.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 CA-C-N 120.984 1.72 . . . . 0.0 107.906 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.81 -52.36 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.432 ' O ' ' NH1' ' A' ' 30' ' ' ARG . 25.4 t90 -47.91 -28.08 2.49 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.447 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.1 mm? -93.43 -21.05 19.74 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.92 -31.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -139.08 29.15 2.27 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.695 1.236 . . . . 0.0 110.388 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.15 9.01 5.11 Favored Glycine 0 N--CA 1.512 3.756 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.744 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.735 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 O-C-N 125.862 1.566 . . . . 0.0 109.242 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.527 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 13.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 116.12 -1.895 . . . . 0.0 106.299 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 8' ' ' SER . . . 82.71 23.75 0.17 Allowed 'General case' 0 N--CA 1.527 3.421 0 O-C-N 125.357 1.661 . . . . 0.0 112.135 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -122.5 -44.91 2.22 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.445 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 3' ' ' GLU . . . -117.85 -52.19 0.32 Allowed Glycine 0 N--CA 1.515 3.962 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 6' ' ' PHE . 50.9 m -149.64 166.41 29.39 Favored 'General case' 0 N--CA 1.524 3.229 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.455 ' N ' HG22 ' A' ' 5' ' ' THR . 20.4 m-85 -31.72 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 118.932 2.938 . . . . 0.0 118.932 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HB ' ' CG ' ' A' ' 1' ' ' HIS . 36.2 p -119.36 -24.92 6.21 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-O 122.878 1.323 . . . . 0.0 111.282 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 42.4 t -124.98 -58.62 1.46 Allowed 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 124.983 2.325 . . . . 0.0 105.267 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -25.24 -54.61 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 109.065 -3.698 . . . . 0.0 109.116 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 3.8 tp10 -57.46 -37.15 72.41 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 21.2 t80 -64.96 -45.14 86.99 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.62 -55.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.58 -40.42 52.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.828 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CZ2' ' NE ' ' A' ' 30' ' ' ARG . 3.4 t90 -43.34 -29.46 0.42 Allowed 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 124.209 1.003 . . . . 0.0 113.684 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 26' ' ' LEU . 9.7 mp -99.27 15.11 27.2 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 123.778 1.752 . . . . 0.0 115.686 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.99 -42.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-O 124.896 2.284 . . . . 0.0 106.365 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 5.9 ttpt -111.33 68.56 0.67 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.463 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.3 -73.66 0.29 Allowed Glycine 1 N--CA 1.525 4.582 0 N-CA-C 122.494 3.758 . . . . 0.0 122.494 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.551 ' NH1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.581 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.675 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.21 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 125.815 1.646 . . . . 0.0 107.334 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.675 ' CD ' ' H2 ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -92.42 -64.4 1.11 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 111.65 -2.523 . . . . 0.0 111.479 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' H ' ' CG ' ' A' ' 3' ' ' GLU . . . -155.35 -69.27 0.01 OUTLIER Glycine 0 N--CA 1.512 3.762 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -114.52 -79.75 0.59 Allowed 'General case' 0 N--CA 1.508 2.475 0 CA-C-N 112.564 -1.818 . . . . 0.0 108.756 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.16 116.71 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -32.09 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -89.41 -14.65 35.01 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -49.22 -43.83 42.82 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 -54.29 -36.92 64.2 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 25' ' ' TRP . 13.6 t80 -73.55 -46.24 48.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.461 ' O ' HD22 ' A' ' 26' ' ' LEU . 95.8 mt -57.11 -49.34 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.543 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.48 -24.59 42.22 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 123.899 1.809 . . . . 0.0 109.384 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . 2.3 t90 -27.65 -58.15 0.11 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 23' ' ' ILE 0.269 0.4 OUTLIER -47.58 -13.99 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 -179.244 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.3 t -99.62 -28.1 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 13.7 ptmt -121.97 52.96 1.23 Allowed 'General case' 0 CA--C 1.582 2.176 0 CA-C-N 112.246 -2.252 . . . . 0.0 114.466 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.97 -66.77 0.42 Allowed Glycine 1 N--CA 1.534 5.178 1 N-CA-C 127.023 5.569 . . . . 0.0 127.023 179.61 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.655 HH11 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.526 3.337 0 CA-C-N 121.915 2.858 . . . . 0.0 117.186 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.601 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 16.9 m-70 . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.78 -42.18 7.56 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 124.571 2.129 . . . . 0.0 112.104 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.774 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -90.35 17.05 7.66 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 109.928 -3.306 . . . . 0.0 114.598 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.17 -64.38 0.26 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 114.773 -1.103 . . . . 0.0 115.159 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -124.23 -72.82 0.66 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' HIS . 48.5 m-85 -1.48 135.14 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 p -132.6 -79.16 0.5 Allowed 'General case' 0 N--CA 1.522 3.158 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 p -40.79 -36.96 0.69 Allowed 'General case' 0 N--CA 1.526 3.353 0 CA-C-O 124.735 2.207 . . . . 0.0 110.907 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -34.9 -53.42 0.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 109.774 -3.376 . . . . 0.0 109.226 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 14' ' ' LEU . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HA ' ' H ' ' A' ' 19' ' ' ALA . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' GLU . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -102.04 -30.3 11.27 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.6 -42.35 83.05 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -47.42 -40.57 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.446 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.15 -35.52 21.66 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.06 -1.882 . . . . 0.0 108.493 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' CD1' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -52.78 -49.06 66.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.844 -1.785 . . . . 0.0 106.824 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 10.8 mp -79.21 17.85 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -121.83 -48.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.518 ' NZ ' ' CD1' ' A' ' 25' ' ' TRP . 58.1 mttt -19.12 -38.33 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -129.72 13.16 5.87 Favored Glycine 1 N--CA 1.523 4.487 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.895 ' NH2' ' HB2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.528 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.1 m80 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.08 -46.87 6.31 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 121.956 2.162 . . . . 0.0 106.92 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -91.2 -47.38 7.55 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.054 -2.339 . . . . 0.0 109.204 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -97.72 85.98 0.79 Allowed Glycine 0 N--CA 1.509 3.564 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.018 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 6' ' ' PHE . 2.4 m -132.27 170.06 15.59 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.179 -1.011 . . . . 0.0 108.389 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 5' ' ' THR . 3.3 m-85 -64.55 55.05 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 119.089 2.996 . . . . 0.0 119.089 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -142.26 -63.42 0.43 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -69.41 -58.55 3.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 111.637 -2.529 . . . . 0.0 107.491 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.18 -55.18 16.2 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 -48.09 -34.38 9.59 Favored 'General case' 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.6 t80 -81.05 -38.44 27.4 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' TRP . 2.5 tp -56.27 -43.79 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.69 24.41 0.06 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.97 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' ILE . 67.4 t90 -127.28 -62.38 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 102.695 -3.076 . . . . 0.0 102.695 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -58.9 -31.65 68.82 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 111.42 -2.627 . . . . 0.0 113.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.46 -35.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.062 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 28' ' ' LYS . 3.5 ttpt -113.81 20.24 16.0 Favored 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.84 -9.16 5.87 Favored Glycine 1 N--CA 1.527 4.755 0 O-C-N 121.781 -0.574 . . . . 0.0 113.167 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' HD3' ' H ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.176 0 O-C-N 126.029 1.664 . . . . 0.0 111.189 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . 0.467 ' C ' ' N ' ' A' ' 3' ' ' GLU . 4.8 t60 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 116.705 -1.617 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . 38.14 32.18 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.763 0 CA-C-O 124.176 1.941 . . . . 0.0 107.944 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 3' ' ' GLU 0.258 0.0 OUTLIER 4.64 61.73 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 110.248 -3.16 . . . . 0.0 112.889 -178.906 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 15.26 46.24 0.01 OUTLIER Glycine 1 N--CA 1.522 4.382 1 CA-C-N 106.164 -5.016 . . . . 0.0 117.113 -179.979 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' GLY . 82.6 m 104.22 48.49 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.625 0 O-C-N 126.145 1.732 . . . . 0.0 114.257 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -55.06 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.2 t -89.87 -158.5 0.53 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -9.89 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 120.825 3.639 . . . . 0.0 120.825 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER -89.18 -82.1 0.26 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 127.373 2.269 . . . . 0.0 108.89 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 17.2 mp0 -50.1 -48.17 53.47 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' CE1' HD22 ' A' ' 26' ' ' LEU . 33.5 t80 -64.7 -44.66 89.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.299 1.047 . . . . 0.0 108.295 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.6 mt -52.26 -54.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.65 -58.6 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 45.5 m0 -32.11 -56.54 0.31 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 26' ' ' LEU . 11.1 mp -90.37 -30.03 17.68 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.91 -53.15 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 121.953 -0.467 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 4.9 tptp -122.65 -8.19 8.51 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.86 -28.04 46.19 Favored Glycine 1 N--CA 1.529 4.89 0 N-CA-C 106.08 -2.808 . . . . 0.0 106.08 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.631 0 CA-C-N 109.655 -3.273 . . . . 0.0 103.11 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 . . . . . 0 N--CA 1.499 1.99 0 CA-C-O 121.423 0.63 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 120.317 0.103 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' GLU . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 . . . . . 0 N--CA 1.477 0.877 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 . . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' A' ' 14' ' ' LEU . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.3 mm-40 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.436 0.636 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 . . . . . 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 N--CA 1.498 1.955 0 CA-C-O 121.0 0.428 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.653 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.653 ' HZ1' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.426 1.1 t0 . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' N ' ' HD3' ' A' ' 20' ' ' LYS . 4.7 pt-20 . . . . . 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.613 0.721 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.538 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 12' ' ' SER . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' HE3' ' A' ' 20' ' ' LYS . 31.9 mt-10 . . . . . 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.045 0.45 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 14' ' ' LEU . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 21' ' ' GLU . 2.2 tm0? -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 4.5 mt-10 . . . . . 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 . . . . . 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 12' ' ' SER 0.255 1.5 p30 . . . . . 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 14' ' ' LEU . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 20' ' ' LYS . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.272 6.1 t0 . . . . . 0 N--CA 1.505 2.321 0 CA-C-O 122.641 1.21 . . . . 0.0 111.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.494 ' NE2' ' HG2' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' NE2' ' A' ' 17' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 . . . . . 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 124.128 1.918 . . . . 0.0 109.116 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 . . . . . 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.88 1.324 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 14' ' ' LEU . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HA ' ' H ' ' A' ' 19' ' ' ALA . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' GLU . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.51 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 . . . . . 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.375 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 17.2 mp0 . . . . . 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 31.8 t60 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 114.628 -2.606 . . . . 0.0 106.053 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 109.57 73.99 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.874 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.251 0.5 OUTLIER -1.28 86.62 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.825 1 CA-C-O 128.655 4.074 . . . . 0.0 117.568 -179.557 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 6' ' ' PHE . . . 140.11 -77.82 0.31 Allowed Glycine 0 N--CA 1.495 2.607 2 N-CA-C 97.75 -6.14 . . . . 0.0 97.75 -179.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 ' O ' ' HB3' ' A' ' 6' ' ' PHE . 50.4 m -20.51 71.99 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.102 0 C-N-CA 126.456 1.903 . . . . 0.0 116.086 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 8' ' ' SER . 7.3 t80 77.04 -65.65 0.28 Allowed 'General case' 0 N--CA 1.511 2.585 0 C-N-CA 126.472 1.909 . . . . 0.0 109.068 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -14.89 -48.32 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.809 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 6' ' ' PHE . 32.7 t -36.52 -55.61 0.84 Allowed 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 113.857 -1.519 . . . . 0.0 112.874 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 10' ' ' VAL . 37.0 t0 -49.85 -80.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.396 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 9' ' ' ASP . 73.8 t -28.94 -52.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.928 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.1 t -62.72 -63.44 1.21 Allowed 'General case' 0 N--CA 1.514 2.749 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.128 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.7 t -44.79 -41.39 6.92 Favored 'General case' 0 N--CA 1.51 2.556 0 CA-C-O 121.915 0.864 . . . . 0.0 109.963 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -58.66 -59.42 5.43 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -41.6 -51.91 3.88 Favored 'General case' 0 N--CA 1.511 2.6 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -55.55 -63.2 1.25 Allowed 'General case' 0 N--CA 1.509 2.512 0 CA-C-O 122.526 1.155 . . . . 0.0 110.363 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.92 -35.02 7.67 Favored Glycine 1 N--CA 1.518 4.138 0 CA-C-N 113.881 -1.509 . . . . 0.0 111.393 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -79.89 -70.2 0.53 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -27.97 -57.78 0.11 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 124.198 0.936 . . . . 0.0 113.462 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -24.63 -41.3 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' GLN . 30.0 mmtm -35.99 -53.25 0.77 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' OE2' ' NZ ' ' A' ' 28' ' ' LYS . 10.1 tp10 -34.79 -55.9 0.56 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -83.25 -45.43 13.84 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.836 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -41.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-O 123.199 1.476 . . . . 0.0 110.402 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.2 -36.71 14.62 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.585 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -31.22 -58.47 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 CA-C-O 123.162 1.458 . . . . 0.0 113.96 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 26' ' ' LEU . 34.1 mt -43.29 -16.25 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 116.812 2.153 . . . . 0.0 116.812 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' C ' ' H ' ' A' ' 29' ' ' GLY . 87.6 t -117.09 -50.89 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 N-CA-C 102.299 -3.223 . . . . 0.0 102.299 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 2.8 tmmt? -83.22 48.0 1.32 Allowed 'General case' 0 N--CA 1.507 2.413 0 CA-C-O 124.472 2.082 . . . . 0.0 106.842 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . -133.26 -15.62 1.28 Allowed Glycine 0 N--CA 1.503 3.138 0 CA-C-N 111.407 -2.633 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.173 0 O-C-N 126.384 1.873 . . . . 0.0 108.723 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.468 ' HA ' ' CG2' ' A' ' 5' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.501 2.097 0 CA-C-O 115.658 -2.115 . . . . 0.0 108.331 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.44 -71.07 0.03 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 CA-C-N 120.996 1.726 . . . . 0.0 113.867 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -101.05 -65.15 0.99 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.18 89.69 0.21 Allowed Glycine 1 N--CA 1.518 4.153 0 N-CA-C 107.581 -2.208 . . . . 0.0 107.581 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 HG23 ' N ' ' A' ' 6' ' ' PHE . 12.7 t 126.5 -158.56 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 130.6 3.56 . . . . 0.0 105.438 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.541 ' N ' HG23 ' A' ' 5' ' ' THR . 5.9 p90 -23.26 71.27 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 119.49 3.144 . . . . 0.0 119.49 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' THR . 3.4 m 165.41 -70.44 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 128.923 2.889 . . . . 0.0 105.231 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 p -56.24 -59.43 4.95 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.389 -0.82 . . . . 0.0 109.589 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.4 p30 -48.12 -51.8 23.19 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.92 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.7 t -36.97 -60.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 m -35.05 -48.04 0.4 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 114.326 -1.306 . . . . 0.0 113.139 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.2 p -82.08 -41.99 19.8 Favored 'General case' 0 N--CA 1.505 2.321 0 C-N-CA 118.875 -1.13 . . . . 0.0 108.87 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -54.66 -36.04 64.17 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.337 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -46.8 -61.07 2.02 Favored 'General case' 0 N--CA 1.515 2.817 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 17' ' ' GLN . 19.4 tp10 -57.64 -45.37 85.54 Favored 'General case' 0 N--CA 1.516 2.858 0 N-CA-C 104.094 -2.558 . . . . 0.0 104.094 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -39.36 -20.66 0.02 OUTLIER Glycine 1 N--CA 1.519 4.213 0 CA-C-N 114.812 -1.085 . . . . 0.0 112.615 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 15' ' ' GLU . 12.6 mm-40 -91.71 -63.27 1.27 Allowed 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.64 -50.44 3.03 Favored 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 124.043 1.878 . . . . 0.0 108.5 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.13 -50.23 11.34 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 113.564 -1.653 . . . . 0.0 108.073 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -64.1 -51.7 62.76 Favored 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -51.05 -21.93 2.11 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 122.073 0.94 . . . . 0.0 111.261 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.529 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 68.0 t80 -95.51 -57.51 2.37 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 96.5 mt -48.41 -38.6 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 CA-C-O 122.937 1.351 . . . . 0.0 110.814 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.39 36.93 1.05 Allowed 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 122.493 1.14 . . . . 0.0 109.358 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.529 ' HB3' ' O ' ' A' ' 22' ' ' PHE . 27.5 t90 -114.14 -83.59 0.61 Allowed 'General case' 0 N--CA 1.509 2.489 0 CA-C-O 122.95 1.357 . . . . 0.0 109.936 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' HD23 ' A' ' 26' ' ' LEU . 1.1 pt? -51.12 -9.12 0.05 Allowed 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 116.766 2.135 . . . . 0.0 116.766 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.83 15.84 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.083 0 CA-C-O 123.548 1.642 . . . . 0.0 110.486 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -144.69 -48.58 0.25 Allowed 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 114.037 -1.438 . . . . 0.0 112.185 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.67 53.03 0.83 Allowed Glycine 0 N--CA 1.513 3.804 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.782 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.507 2.399 0 CA-C-O 115.281 -2.295 . . . . 0.0 110.668 -179.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 24.9 p80 . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.62 -55.13 1.15 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 101.666 -3.457 . . . . 0.0 101.666 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.525 ' OE2' ' HA ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -87.74 50.61 2.03 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 111.557 -2.565 . . . . 0.0 107.143 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 7' ' ' THR . . . 8.98 -98.7 0.01 OUTLIER Glycine 1 N--CA 1.527 4.713 0 CA-C-N 113.289 -1.778 . . . . 0.0 116.255 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.6 m -39.46 -27.14 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 10' ' ' VAL . 12.1 m-85 -107.89 -5.5 17.17 Favored 'General case' 0 N--CA 1.508 2.464 0 CA-C-O 125.037 2.351 . . . . 0.0 114.338 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.525 ' HA ' ' OE2' ' A' ' 3' ' ' GLU . 7.3 t 10.2 26.16 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.251 1 N-CA-C 126.621 5.786 . . . . 0.0 126.621 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t 76.54 16.48 2.01 Favored 'General case' 0 N--CA 1.535 3.793 0 CA-C-O 124.596 2.141 . . . . 0.0 110.103 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.753 ' HA ' ' CE2' ' A' ' 13' ' ' TYR 0.253 5.3 t70 -125.68 -91.41 0.53 Allowed 'General case' 0 C--N 1.29 -1.995 1 N-CA-C 99.38 -4.304 . . . . 0.0 99.38 -179.998 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 6' ' ' PHE . 41.7 t -32.59 -57.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-N 112.345 -2.207 . . . . 0.0 109.839 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.5 m -39.38 -45.08 1.42 Allowed 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 113.7 -1.591 . . . . 0.0 114.896 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.5 p -100.82 -34.83 9.66 Favored 'General case' 0 N--CA 1.508 2.458 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.753 ' CE2' ' HA ' ' A' ' 9' ' ' ASP . 1.1 m-30 -88.36 -46.45 9.16 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -66.08 -40.56 90.93 Favored 'General case' 0 N--CA 1.509 2.482 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.979 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -102.55 -73.46 0.66 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 179.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -29.2 -47.71 0.09 OUTLIER Glycine 0 N--CA 1.515 3.912 0 CA-C-N 114.722 -1.126 . . . . 0.0 115.703 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -103.34 -67.64 0.88 Allowed 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -24.93 -51.93 0.03 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 120.071 3.36 . . . . 0.0 120.071 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.74 4.57 21.45 Favored 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 15' ' ' GLU . 11.2 mptt -109.01 -50.01 3.06 Favored 'General case' 0 C--N 1.29 -2.003 1 N-CA-C 96.673 -5.306 . . . . 0.0 96.673 178.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' O ' ' CD1' ' A' ' 25' ' ' TRP . 53.3 mm-40 -44.98 -62.48 1.22 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 122.356 1.074 . . . . 0.0 109.585 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.94 38.3 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 124.802 2.239 . . . . 0.0 112.007 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.453 ' H ' ' C ' ' A' ' 21' ' ' GLU . 0.6 OUTLIER -127.07 -47.96 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 177.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' LYS . . . -73.04 -53.51 10.95 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 112.568 -2.105 . . . . 0.0 112.019 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 44.6 m0 -23.66 -55.01 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 123.435 1.588 . . . . 0.0 114.021 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 30' ' ' ARG . 4.4 mm? -100.84 73.62 1.58 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 112.6 -2.091 . . . . 0.0 112.658 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 m 45.32 28.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 110.658 -2.974 . . . . 0.0 113.84 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.619 ' NZ ' ' HB2' ' A' ' 28' ' ' LYS . 0.4 OUTLIER 73.05 43.45 0.4 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 112.938 -1.937 . . . . 0.0 109.39 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -134.25 -49.36 0.08 OUTLIER Glycine 0 N--CA 1.505 3.257 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.568 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.696 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.658 0 CA-C-O 116.658 -1.639 . . . . 0.0 110.581 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.53 ' CG ' ' HB3' ' A' ' 6' ' ' PHE . 54.2 m170 . . . . . 0 N--CA 1.507 2.383 0 CA-C-O 116.569 -1.682 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -39.69 151.72 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 CA-C-N 119.935 1.243 . . . . 0.0 110.595 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 36.18 25.68 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.734 0 CA-C-O 124.894 2.283 . . . . 0.0 115.651 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.5 -68.63 0.42 Allowed Glycine 0 N--CA 1.512 3.738 0 O-C-N 119.601 -1.937 . . . . 0.0 112.483 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 p 20.6 -101.28 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.419 0 N-CA-C 116.293 1.96 . . . . 0.0 116.293 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.53 ' HB3' ' CG ' ' A' ' 1' ' ' HIS . 62.1 t80 -69.55 108.07 3.66 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.382 -1.449 . . . . 0.0 108.655 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 t 173.51 -38.08 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.837 0 CA-C-N 111.153 -2.749 . . . . 0.0 105.752 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.7 p -26.02 -55.14 0.06 Allowed 'General case' 0 N--CA 1.513 2.707 0 CA-C-N 112.92 -1.945 . . . . 0.0 115.624 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.275 4.1 t70 -60.18 -86.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.095 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -34.55 -45.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.442 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 t -64.84 -61.24 2.29 Favored 'General case' 0 N--CA 1.512 2.668 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.8 t -42.97 -47.39 5.72 Favored 'General case' 0 N--CA 1.513 2.713 0 CA-C-O 123.496 1.617 . . . . 0.0 110.7 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -57.1 -28.07 62.33 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 113.986 -1.461 . . . . 0.0 114.093 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mp -94.35 -62.43 1.34 Allowed 'General case' 0 N--CA 1.51 2.527 0 C-N-CA 126.048 1.739 . . . . 0.0 109.016 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -51.0 -43.04 60.75 Favored 'General case' 0 N--CA 1.515 2.808 0 CA-C-O 125.207 2.432 . . . . 0.0 104.989 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.36 -33.09 58.11 Favored Glycine 0 N--CA 1.51 3.567 0 CA-C-N 111.674 -2.512 . . . . 0.0 110.472 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -39.86 -54.92 2.08 Favored 'General case' 0 N--CA 1.521 3.09 0 CA-C-O 122.153 0.977 . . . . 0.0 108.485 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -41.95 -42.35 2.77 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 111.749 -2.478 . . . . 0.0 112.421 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.62 -51.39 6.89 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.252 -1.34 . . . . 0.0 108.865 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -36.23 -52.56 0.8 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-O 122.168 0.985 . . . . 0.0 110.832 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 19.2 tp10 -48.99 -53.09 21.4 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.395 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HA ' ' CG ' ' A' ' 25' ' ' TRP . 15.7 t80 -63.41 -46.73 85.04 Favored 'General case' 0 N--CA 1.5 2.038 0 CA-C-O 123.628 1.68 . . . . 0.0 106.717 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.58 -14.94 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 112.414 -2.175 . . . . 0.0 111.442 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.15 -35.41 8.91 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.299 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 41.7 m0 -28.6 -66.85 0.08 Allowed 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -43.45 -18.1 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 111.448 -2.614 . . . . 0.0 115.91 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -114.49 -44.85 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.478 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 61.6 mtpt -51.44 -46.08 62.89 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.768 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 30' ' ' ARG . . . -141.11 -30.16 0.17 Allowed Glycine 0 N--CA 1.513 3.775 0 CA-C-N 113.765 -1.561 . . . . 0.0 115.127 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.581 ' NH2' ' HB3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.536 0 C-N-CA 129.282 3.033 . . . . 0.0 105.932 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 . . . . . 0 N--CA 1.506 2.368 0 CA-C-O 122.699 1.238 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -137.81 -53.46 0.65 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 6.5 mp0 -5.54 -60.27 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 112.079 -2.328 . . . . 0.0 116.606 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.91 55.56 4.91 Favored Glycine 0 N--CA 1.51 3.623 0 CA-C-N 114.958 -1.019 . . . . 0.0 113.353 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.4 m 66.4 -33.12 0.19 Allowed 'General case' 0 N--CA 1.528 3.447 0 N-CA-C 117.968 2.581 . . . . 0.0 117.968 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.489 ' CG ' ' N ' ' A' ' 7' ' ' THR . 9.1 t80 40.78 -102.35 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.4 0 CA-C-O 116.859 -1.543 . . . . 0.0 113.413 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.489 ' N ' ' CG ' ' A' ' 6' ' ' PHE . 57.0 p 4.11 -75.85 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.792 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.5 m -32.43 -42.42 0.07 Allowed 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -28.36 -49.61 0.07 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.008 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -28.69 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.45 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.954 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.7 m -86.34 -74.11 0.43 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 103.867 -2.642 . . . . 0.0 103.867 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.7 m -28.58 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 115.886 1.81 . . . . 0.0 115.886 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -64.53 -65.88 0.62 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.838 1.304 . . . . 0.0 107.622 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.26 -44.63 96.11 Favored 'General case' 0 N--CA 1.514 2.729 0 CA-C-O 123.343 1.544 . . . . 0.0 108.76 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.342 30.4 tt0 -52.07 -49.02 64.36 Favored 'General case' 0 N--CA 1.506 2.33 0 CA-C-N 113.044 -1.889 . . . . 0.0 106.193 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.58 -55.08 30.54 Favored Glycine 0 N--CA 1.513 3.817 0 N-CA-C 107.536 -2.225 . . . . 0.0 107.536 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -49.18 -58.89 4.23 Favored 'General case' 0 N--CA 1.511 2.588 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 22' ' ' PHE . . . -43.92 -53.17 6.35 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.213 1.006 . . . . 0.0 110.808 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.51 -27.93 12.05 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.291 1.043 . . . . 0.0 111.373 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 0.4 OUTLIER -95.28 -35.33 11.85 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -48.23 2.97 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.406 ' CZ ' HD11 ' A' ' 26' ' ' LEU . 47.8 t80 -54.03 -44.4 70.95 Favored 'General case' 0 N--CA 1.507 2.389 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 24' ' ' ALA . 8.4 tp -43.33 -49.41 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-N 112.024 -2.353 . . . . 0.0 110.5 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' N ' HG23 ' A' ' 23' ' ' ILE . . . -62.77 -47.48 83.32 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.194 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.521 ' CD2' ' NZ ' ' A' ' 28' ' ' LYS . 1.5 t90 -46.96 -36.04 7.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.438 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD11 ' CZ ' ' A' ' 22' ' ' PHE . 82.6 mt -107.8 33.58 4.0 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-O 124.389 2.043 . . . . 0.0 114.917 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.4 t -130.13 -50.16 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.077 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' NZ ' ' CD2' ' A' ' 25' ' ' TRP . 4.6 pttt -19.79 -53.35 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.8 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.21 44.61 1.15 Allowed Glycine 0 N--CA 1.515 3.962 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.623 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.458 ' C ' HH21 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.162 0 O-C-N 125.449 1.323 . . . . 0.0 111.248 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.7 m170 . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 122.499 1.143 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.559 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -150.01 -65.04 0.21 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 102.145 -3.28 . . . . 0.0 102.145 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER -33.89 -48.96 0.32 Allowed 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 113.568 -1.651 . . . . 0.0 111.371 179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -26.93 -39.26 0.01 OUTLIER Glycine 0 N--CA 1.516 3.985 0 N-CA-C 117.91 1.924 . . . . 0.0 117.91 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 7' ' ' THR . 67.5 p -106.35 19.95 19.72 Favored 'General case' 0 N--CA 1.526 3.34 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 8' ' ' SER . 36.2 p90 6.64 -54.63 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 121.512 3.893 . . . . 0.0 121.512 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.546 HG23 ' H ' ' A' ' 8' ' ' SER . 1.3 t 38.17 -65.02 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 118.527 2.788 . . . . 0.0 118.527 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.546 ' H ' HG23 ' A' ' 7' ' ' THR . 12.0 m -91.43 -36.85 13.54 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.242 -0.911 . . . . 0.0 110.091 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.28 0.1 OUTLIER -50.47 -75.23 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 122.046 0.927 . . . . 0.0 109.308 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 11' ' ' SER . 5.5 p -28.34 -54.84 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.962 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 10' ' ' VAL . 69.2 m -69.6 -47.79 62.29 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.436 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.3 t -38.31 -35.88 0.2 Allowed 'General case' 0 N--CA 1.521 3.108 0 CA-C-O 122.821 1.296 . . . . 0.0 108.918 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -92.46 -60.76 1.75 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 111.463 -2.608 . . . . 0.0 111.502 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tt -54.43 -61.12 2.51 Favored 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 123.398 0.679 . . . . 0.0 109.683 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' A' ' 17' ' ' GLN . 0.8 OUTLIER -55.41 -40.63 71.68 Favored 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.29 -3.01 2.48 Favored Glycine 1 N--CA 1.526 4.682 0 CA-C-N 113.092 -1.867 . . . . 0.0 111.532 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.653 ' HA ' ' HZ1' ' A' ' 20' ' ' LYS . 0.3 OUTLIER -111.23 -69.26 0.88 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -29.72 -49.93 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 123.037 1.398 . . . . 0.0 111.14 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.36 13.13 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.458 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.653 ' HZ1' ' HA ' ' A' ' 17' ' ' GLN . 10.3 mttp -56.42 -53.47 57.06 Favored 'General case' 0 N--CA 1.514 2.754 0 CA-C-O 122.667 1.222 . . . . 0.0 110.273 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -59.35 -41.99 90.51 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.106 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -62.85 -46.32 88.45 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 104.116 -2.55 . . . . 0.0 104.116 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -52.08 -52.0 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 117.841 -1.543 . . . . 0.0 108.388 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.5 -50.65 9.38 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.142 -0.974 . . . . 0.0 110.676 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 9.9 t90 -30.55 -54.13 0.19 Allowed 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 124.427 2.06 . . . . 0.0 113.341 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD13 ' H ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -104.17 -23.91 13.22 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 110.603 -2.999 . . . . 0.0 118.278 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.546 ' N ' HD22 ' A' ' 26' ' ' LEU . 21.1 m -82.08 -27.51 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.084 0 CA-C-N 120.758 1.617 . . . . 0.0 108.275 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -131.36 -24.18 2.31 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 118.334 2.716 . . . . 0.0 118.334 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.53 50.65 0.79 Allowed Glycine 1 N--CA 1.519 4.169 0 O-C-N 124.561 1.163 . . . . 0.0 114.994 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.755 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.503 ' N ' ' OG1' ' A' ' 5' ' ' THR . 37.9 m170 . . . . . 0 N--CA 1.504 2.265 0 CA-C-O 117.189 -1.386 . . . . 0.0 109.831 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.481 ' HB1' ' CE2' ' A' ' 6' ' ' PHE . . . 110.89 -147.25 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.025 0 C-N-CA 127.649 2.38 . . . . 0.0 104.971 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -89.8 58.48 4.26 Favored 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.57 -128.97 6.48 Favored Glycine 0 N--CA 1.51 3.578 0 N-CA-C 105.092 -3.203 . . . . 0.0 105.092 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.528 ' C ' ' HB3' ' A' ' 9' ' ' ASP . 30.9 m -142.96 48.66 1.49 Allowed 'General case' 0 N--CA 1.525 3.304 0 O-C-N 120.745 -1.444 . . . . 0.0 112.543 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.481 ' CE2' ' HB1' ' A' ' 2' ' ' ALA . 10.5 m-30 -12.75 -55.85 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.741 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -33.16 -48.43 0.22 Allowed 'General case' 0 N--CA 1.528 3.445 0 CA-C-O 122.862 1.315 . . . . 0.0 113.815 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.7 m -106.96 -44.64 4.36 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-N 112.425 -2.17 . . . . 0.0 108.959 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' HB3' ' C ' ' A' ' 5' ' ' THR 0.426 1.1 t0 -47.91 -87.93 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 112.705 -2.043 . . . . 0.0 107.374 179.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.7 t -40.81 -53.5 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.047 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.4 m -41.04 -53.59 2.98 Favored 'General case' 0 N--CA 1.52 3.062 0 CA-C-O 121.138 0.494 . . . . 0.0 111.425 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.9 m -42.56 -47.94 5.27 Favored 'General case' 0 N--CA 1.518 2.963 0 CA-C-O 122.932 1.348 . . . . 0.0 111.311 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.98 -52.52 58.02 Favored 'General case' 0 N--CA 1.508 2.467 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.429 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 14' ' ' LEU . 8.5 mp -57.81 -54.83 42.42 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 114.102 -1.408 . . . . 0.0 108.284 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -38.45 -53.89 1.51 Allowed 'General case' 0 N--CA 1.513 2.711 0 CA-C-O 123.888 1.804 . . . . 0.0 108.0 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -46.86 -50.83 14.25 Favored Glycine 1 N--CA 1.518 4.155 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.209 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -49.02 -25.23 1.88 Allowed 'General case' 0 N--CA 1.514 2.754 0 CA-C-N 114.479 -0.86 . . . . 0.0 112.421 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.2 -57.52 2.31 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -26.32 -58.91 0.08 Allowed 'General case' 0 N--CA 1.507 2.375 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -32.18 -29.5 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 118.018 2.599 . . . . 0.0 118.018 -179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 4.7 pt-20 -102.46 -41.53 6.27 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.9 t80 -57.95 -39.9 79.23 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.7 mt -52.44 -44.54 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 112.389 -2.187 . . . . 0.0 108.025 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 30' ' ' ARG . . . -55.34 -58.26 8.47 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.634 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.609 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -31.0 -49.99 0.14 Allowed 'General case' 0 N--CA 1.521 3.123 0 CA-C-O 125.093 2.377 . . . . 0.0 113.404 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.304 62.4 tp -100.3 -16.39 17.7 Favored 'General case' 0 C--N 1.288 -2.083 1 CA-C-N 108.117 -4.129 . . . . 0.0 120.687 -178.97 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 38.9 t -84.86 -31.28 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.472 0 O-C-N 121.226 -0.921 . . . . 0.0 110.498 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' NZ ' ' OXT' ' A' ' 30' ' ' ARG . 0.4 OUTLIER 139.86 67.45 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.892 0 C-N-CA 126.583 1.953 . . . . 0.0 111.73 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.418 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . 81.6 -40.43 2.6 Favored Glycine 1 N--CA 1.523 4.462 0 C-N-CA 119.64 -1.267 . . . . 0.0 115.752 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.593 ' NH1' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 C-N-CA 126.24 1.816 . . . . 0.0 107.716 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.663 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 43.3 t60 . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' H ' ' CG ' ' A' ' 1' ' ' HIS . . . -29.77 -36.69 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.687 0 CA-C-N 123.907 3.049 . . . . 0.0 117.289 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -84.02 -5.13 59.17 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 118.945 2.942 . . . . 0.0 118.945 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 17.64 46.45 0.01 OUTLIER Glycine 1 N--CA 1.524 4.53 0 N-CA-C 117.544 1.778 . . . . 0.0 117.544 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -127.75 -156.39 0.75 Allowed 'General case' 0 N--CA 1.512 2.639 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' O ' ' N ' ' A' ' 8' ' ' SER . 67.9 m-85 67.29 -71.93 0.1 Allowed 'General case' 0 N--CA 1.518 2.969 0 C-N-CA 124.591 1.156 . . . . 0.0 111.427 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p 41.24 -67.66 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.451 0 N-CA-C 116.899 2.185 . . . . 0.0 116.899 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 6' ' ' PHE . 65.1 m -35.36 -38.46 0.1 Allowed 'General case' 0 N--CA 1.517 2.907 0 C-N-CA 126.92 2.088 . . . . 0.0 115.326 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CG ' ' H ' ' A' ' 10' ' ' VAL . 11.9 p-10 -95.11 -65.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 112.88 -1.963 . . . . 0.0 109.415 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.538 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 88.1 t -32.35 -50.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 CA-C-O 122.861 1.315 . . . . 0.0 111.66 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 13' ' ' TYR . 13.4 p -55.01 -78.25 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 CA-C-N 113.976 -1.465 . . . . 0.0 108.691 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . 9.0 t -34.79 -24.35 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' SER . 63.2 t80 -93.48 -52.09 4.66 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.5 tt -92.45 -48.66 6.53 Favored 'General case' 0 N--CA 1.514 2.762 0 CA-C-O 121.956 0.884 . . . . 0.0 110.204 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' CD ' ' N ' ' A' ' 16' ' ' GLY . 0.3 OUTLIER -69.52 -49.51 53.85 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 103.951 -2.611 . . . . 0.0 103.951 179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 12' ' ' SER . . . -16.91 -56.66 0.01 OUTLIER Glycine 0 N--CA 1.498 2.828 0 CA-C-N 111.861 -2.427 . . . . 0.0 117.006 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.42 -45.33 13.79 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 113.655 -1.272 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.53 -42.22 54.86 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.3 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -122.64 -70.13 0.79 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 12' ' ' SER . 24.8 ttpt -35.5 -59.41 0.55 Allowed 'General case' 0 N--CA 1.513 2.724 0 N-CA-C 115.429 1.641 . . . . 0.0 115.429 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' HG3' ' HE3' ' A' ' 20' ' ' LYS . 31.9 mt-10 -62.47 -36.94 84.06 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.388 -0.82 . . . . 0.0 110.478 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.46 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 2.3 t80 -65.12 -44.0 90.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.1 mt -53.4 -47.16 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.13 -49.88 40.01 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.46 ' CD1' ' HA ' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -50.92 -67.72 0.23 Allowed 'General case' 0 N--CA 1.52 3.026 0 CA-C-O 124.95 2.309 . . . . 0.0 107.769 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.297 4.2 tt -31.23 -40.38 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 108.892 -3.776 . . . . 0.0 113.003 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 m -100.87 -41.86 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -122.62 17.04 10.38 Favored 'General case' 0 N--CA 1.521 3.091 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.48 -54.14 0.15 Allowed Glycine 1 N--CA 1.525 4.575 0 N-CA-C 106.194 -2.763 . . . . 0.0 106.194 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.57 1 C-N-CA 131.989 4.115 . . . . 0.0 111.643 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' A' ' 2' ' ' ALA . 58.7 t-80 . . . . . 0 N--CA 1.507 2.391 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.472 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 4' ' ' GLY . . . -66.3 170.85 5.38 Favored 'General case' 0 CA--C 1.588 2.422 1 N-CA-C 98.651 -4.574 . . . . 0.0 98.651 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 26.33 12.51 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.54 0 N-CA-C 121.217 3.784 . . . . 0.0 121.217 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . -155.5 76.63 0.21 Allowed Glycine 0 N--CA 1.509 3.511 0 O-C-N 119.842 -1.786 . . . . 0.0 113.459 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 94.1 m -132.51 60.02 1.7 Allowed 'General case' 0 N--CA 1.519 3.023 0 CA-C-O 123.1 1.429 . . . . 0.0 109.951 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 8' ' ' SER . 58.6 m-85 29.38 -66.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.565 HG23 ' H ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 34.38 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.565 ' H ' HG23 ' A' ' 7' ' ' THR . 16.7 p -41.78 -50.76 4.31 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -74.45 -64.71 0.97 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.297 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -39.95 -48.88 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 119.137 -0.459 . . . . 0.0 112.173 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' SER . 89.1 p -74.27 -55.6 5.85 Favored 'General case' 0 N--CA 1.515 2.825 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' SER . 40.6 t -34.86 -43.73 0.2 Allowed 'General case' 0 N--CA 1.525 3.32 0 CA-C-O 122.163 0.982 . . . . 0.0 109.781 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -75.11 -59.51 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 112.906 -1.952 . . . . 0.0 108.219 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 14' ' ' LEU . 5.4 tt -45.77 -60.58 2.14 Favored 'General case' 0 N--CA 1.51 2.527 0 CA-C-N 118.64 0.654 . . . . 0.0 111.449 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -52.69 -56.88 12.34 Favored 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 122.841 1.305 . . . . 0.0 109.014 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.19 -36.11 28.17 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-O 123.925 1.847 . . . . 0.0 112.494 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.446 ' NE2' ' HB2' ' A' ' 21' ' ' GLU . 2.2 tm0? -73.0 -68.58 0.48 Allowed 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.01 -55.92 3.56 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.474 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -32.16 -36.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.562 ' HZ1' ' CD ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -113.89 -61.43 1.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.039 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.562 ' CD ' ' HZ1' ' A' ' 20' ' ' LYS . 4.5 mt-10 -56.5 -37.21 70.09 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 27.3 t80 -79.56 -45.18 19.71 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 tt -52.41 -47.59 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.37 -63.92 1.03 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.552 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -29.03 -63.73 0.11 Allowed 'General case' 0 N--CA 1.514 2.758 0 CA-C-O 124.916 2.294 . . . . 0.0 112.98 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.552 ' N ' ' CG ' ' A' ' 25' ' ' TRP . 63.2 tp -46.88 -31.29 3.01 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 110.523 -3.035 . . . . 0.0 115.401 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' HB ' ' NH1' ' A' ' 30' ' ' ARG . 93.2 t 115.16 55.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.855 0 C-N-CA 130.766 3.626 . . . . 0.0 105.547 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt 62.93 15.46 8.36 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-N 111.67 -2.514 . . . . 0.0 116.521 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.86 54.78 0.58 Allowed Glycine 1 N--CA 1.529 4.871 0 C-N-CA 119.957 -1.116 . . . . 0.0 115.349 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.637 ' C ' HH21 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 117.36 -1.305 . . . . 0.0 107.894 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.412 ' N ' ' O ' ' A' ' 5' ' ' THR . 20.4 m-70 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -29.87 -39.55 0.02 OUTLIER 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -111.34 -23.56 10.72 Favored 'General case' 0 C--N 1.287 -2.147 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.818 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.87 -71.19 0.41 Allowed Glycine 0 N--CA 1.508 3.481 0 CA-C-N 113.478 -1.692 . . . . 0.0 111.643 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 1' ' ' HIS . 45.4 m -8.59 143.81 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.572 0 N-CA-C 121.149 3.759 . . . . 0.0 121.149 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.51 58.99 0.19 Allowed 'General case' 0 N--CA 1.51 2.57 0 CA-C-O 124.862 2.267 . . . . 0.0 115.434 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.04 -46.65 88.81 Favored 'General case' 0 N--CA 1.512 2.664 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.71 -62.06 1.89 Allowed 'General case' 0 N--CA 1.511 2.598 0 CA-C-N 113.863 -1.517 . . . . 0.0 107.413 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -42.88 -69.04 0.15 Allowed 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 111.272 -2.695 . . . . 0.0 108.758 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.5 t -45.08 -63.54 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.473 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 62.8 p -53.77 -58.36 7.51 Favored 'General case' 0 N--CA 1.514 2.741 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.972 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.6 t -51.21 -51.89 49.67 Favored 'General case' 0 N--CA 1.507 2.391 0 CA-C-O 121.48 0.657 . . . . 0.0 111.329 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -52.39 -51.98 56.14 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.667 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.93 -55.18 38.23 Favored 'General case' 0 N--CA 1.503 2.186 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.041 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 17' ' ' GLN . 14.1 tp10 -48.8 -54.2 16.09 Favored 'General case' 0 N--CA 1.506 2.348 0 CA-C-O 121.345 0.593 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -31.6 -31.19 0.01 OUTLIER Glycine 1 N--CA 1.526 4.699 0 CA-C-O 122.609 1.116 . . . . 0.0 115.181 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 15' ' ' GLU . 39.5 mt-30 -96.61 -55.6 2.86 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.43 -57.44 5.33 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.702 0.763 . . . . 0.0 109.52 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -38.4 -49.17 1.43 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.425 1.107 . . . . 0.0 109.94 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.01 -55.13 13.77 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.387 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -49.01 -41.89 36.12 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 122.112 0.958 . . . . 0.0 111.146 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' HA ' ' CB ' ' A' ' 25' ' ' TRP . 33.2 m-85 -77.12 -46.01 24.97 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 117.214 -1.374 . . . . 0.0 111.305 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -38.53 -45.77 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 CA-C-O 123.696 1.713 . . . . 0.0 110.744 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.6 -46.74 18.62 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.497 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CB ' ' HA ' ' A' ' 22' ' ' PHE . 22.3 t90 -40.26 -57.87 1.63 Allowed 'General case' 0 N--CA 1.517 2.894 0 CA-C-O 124.223 1.963 . . . . 0.0 110.429 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.7 mt -53.17 -11.07 0.23 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 110.016 -3.265 . . . . 0.0 116.998 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.37 -40.97 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.748 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' NZ ' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -139.34 26.72 2.36 Favored 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 118.577 2.806 . . . . 0.0 118.577 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.17 -39.73 2.65 Favored Glycine 1 N--CA 1.529 4.898 0 N-CA-C 119.527 2.571 . . . . 0.0 119.527 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.498 HH12 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.262 0 C-N-CA 126.431 1.892 . . . . 0.0 108.817 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 9' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.264 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.69 -99.42 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -99.82 61.64 1.14 Allowed 'General case' 0 N--CA 1.504 2.252 1 N-CA-C 98.013 -4.81 . . . . 0.0 98.013 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.37 -157.63 19.17 Favored Glycine 0 N--CA 1.506 3.322 1 N-CA-C 124.866 4.707 . . . . 0.0 124.866 -178.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 7' ' ' THR . 54.7 m 116.0 -133.98 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.055 0 CA-C-N 109.189 -3.505 . . . . 0.0 102.544 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 10' ' ' VAL . 95.4 m-85 -80.36 37.29 0.39 Allowed 'General case' 0 N--CA 1.512 2.666 0 CA-C-N 121.855 2.116 . . . . 0.0 112.196 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' THR . 0.8 OUTLIER -130.25 88.8 2.7 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 113.624 -1.626 . . . . 0.0 107.692 179.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.0 t 74.78 -52.63 0.68 Allowed 'General case' 0 N--CA 1.514 2.744 0 CA-C-N 114.695 -1.138 . . . . 0.0 113.38 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 1' ' ' HIS . 0.7 OUTLIER -45.62 -67.81 0.25 Allowed 'General case' 0 N--CA 1.509 2.52 0 CA-C-O 123.202 1.477 . . . . 0.0 109.257 -179.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 6' ' ' PHE . 10.0 t -37.0 -48.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 CA-C-N 113.702 -1.59 . . . . 0.0 112.118 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.7 t -64.07 -58.84 5.48 Favored 'General case' 0 N--CA 1.511 2.603 0 CA-C-N 113.883 -1.508 . . . . 0.0 107.998 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -42.27 -47.39 4.76 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-O 121.472 0.653 . . . . 0.0 110.234 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -52.59 -58.35 7.08 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 tt -47.32 -57.79 4.85 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -44.67 -53.53 7.15 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-O 122.8 1.286 . . . . 0.0 112.76 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.9 -18.47 72.49 Favored Glycine 0 N--CA 1.513 3.797 0 CA-C-N 114.587 -1.188 . . . . 0.0 115.809 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -112.13 -58.27 2.16 Favored 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -30.93 -52.12 0.17 Allowed 'General case' 0 N--CA 1.514 2.773 0 CA-C-O 123.687 1.708 . . . . 0.0 111.898 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.89 -56.04 5.94 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 113.006 -1.907 . . . . 0.0 108.747 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -64.46 -53.3 50.43 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.627 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -44.03 -44.08 7.14 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 122.514 1.149 . . . . 0.0 111.205 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.454 ' HA ' ' HB3' ' A' ' 25' ' ' TRP . 51.3 t80 -79.28 -47.68 15.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mt -45.7 -46.7 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 CA-C-O 122.415 1.102 . . . . 0.0 108.735 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.93 -62.08 2.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 113.253 -1.794 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -29.4 -53.94 0.14 Allowed 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.568 1.652 . . . . 0.0 115.242 179.254 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.254 2.6 tt -75.17 3.95 7.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 118.857 2.91 . . . . 0.0 118.857 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t 95.37 66.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.541 1 N-CA-C 99.888 -4.115 . . . . 0.0 99.888 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.448 ' NZ ' ' OXT' ' A' ' 30' ' ' ARG . 0.0 OUTLIER 29.76 39.6 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.55 -10.74 66.89 Favored Glycine 1 N--CA 1.526 4.691 0 N-CA-C 120.073 2.789 . . . . 0.0 120.073 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.559 ' HA ' ' NH1' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.524 3.27 0 C-N-CA 128.376 2.67 . . . . 0.0 106.096 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.423 ' CA ' ' OE1' ' A' ' 3' ' ' GLU . 3.3 t60 . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 1' ' ' HIS . . . 116.45 -53.61 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 128.9 2.88 . . . . 0.0 104.865 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER -25.11 -53.49 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.668 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.997 179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -17.47 -45.76 0.01 OUTLIER Glycine 1 N--CA 1.525 4.615 0 C-N-CA 124.437 1.017 . . . . 0.0 115.181 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 3' ' ' GLU . 58.6 p -37.54 -36.57 0.17 Allowed 'General case' 0 N--CA 1.522 3.152 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' A' ' 8' ' ' SER . 37.3 t80 -103.73 27.51 7.43 Favored 'General case' 0 N--CA 1.508 2.454 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -12.48 -37.05 0.0 OUTLIER 'General case' 0 N--CA 1.534 3.768 0 N-CA-C 118.904 2.927 . . . . 0.0 118.904 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.576 ' N ' ' O ' ' A' ' 6' ' ' PHE . 55.6 m -47.63 -33.47 6.75 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 12' ' ' SER 0.255 1.5 p30 -46.76 -56.62 5.92 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.6 t -50.96 -46.06 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.448 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.25 -57.1 13.65 Favored 'General case' 0 N--CA 1.517 2.893 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 16' ' ' GLY . 30.3 t -41.73 -51.43 4.13 Favored 'General case' 0 N--CA 1.516 2.864 0 CA-C-O 121.748 0.785 . . . . 0.0 110.964 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -43.09 -34.7 1.11 Allowed 'General case' 0 N--CA 1.515 2.79 0 CA-C-O 122.232 1.015 . . . . 0.0 111.391 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 14' ' ' LEU . 9.6 mp -91.46 -58.08 2.56 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.174 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -54.96 -65.8 0.52 Allowed 'General case' 0 N--CA 1.52 3.044 0 CA-C-O 123.573 1.654 . . . . 0.0 110.388 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -39.99 -38.36 1.2 Allowed Glycine 1 N--CA 1.516 4.027 0 CA-C-N 111.839 -2.437 . . . . 0.0 110.595 179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -83.2 -73.67 0.4 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 112.856 -1.672 . . . . 0.0 107.583 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -24.57 -49.19 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 125.724 1.61 . . . . 0.0 114.224 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 20' ' ' LYS . . . -31.45 -39.95 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.574 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 18.7 mmtm -75.68 -50.12 16.33 Favored 'General case' 0 N--CA 1.514 2.771 0 CA-C-O 123.082 1.42 . . . . 0.0 107.721 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 75.5 tt0 -50.4 -41.88 52.87 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.222 -1.353 . . . . 0.0 109.472 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 25' ' ' TRP . 56.9 t80 -61.91 -46.1 90.84 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 89.8 mt -50.87 -54.19 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 117.136 -1.825 . . . . 0.0 107.785 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.19 -56.82 14.59 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.546 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.457 ' CD1' ' HG2' ' A' ' 21' ' ' GLU . 1.6 m95 -26.34 -52.87 0.05 Allowed 'General case' 0 N--CA 1.51 2.526 0 C-N-CA 125.11 1.364 . . . . 0.0 113.51 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 25' ' ' TRP . 4.9 mp -91.59 -46.41 7.96 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 111.405 -2.634 . . . . 0.0 112.814 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.1 t -49.72 -40.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.687 0 O-C-N 120.27 -1.519 . . . . 0.0 110.291 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.85 62.39 6.9 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.871 0.843 . . . . 0.0 110.711 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.43 11.79 4.47 Favored Glycine 1 N--CA 1.524 4.566 0 N-CA-C 122.86 3.904 . . . . 0.0 122.86 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.541 ' C ' ' HE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.201 0 CA-C-N 119.855 1.827 . . . . 0.0 108.5 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.52 ' HA ' HG21 ' A' ' 7' ' ' THR . 41.6 m-70 . . . . . 0 N--CA 1.502 2.131 0 CA-C-O 123.051 1.405 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.31 145.55 31.28 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 -62.59 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.101 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.77 -60.53 0.42 Allowed Glycine 0 N--CA 1.513 3.8 0 N-CA-C 104.512 -3.435 . . . . 0.0 104.512 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 7' ' ' THR . 94.8 m -44.82 157.44 0.07 Allowed 'General case' 0 N--CA 1.505 2.289 0 CA-C-N 113.981 -1.109 . . . . 0.0 109.653 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.2 t80 60.6 -18.83 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.322 0 CA-C-O 122.662 1.22 . . . . 0.0 112.694 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.52 HG21 ' HA ' ' A' ' 1' ' ' HIS . 91.2 m -91.96 71.5 5.57 Favored 'General case' 0 N--CA 1.509 2.489 0 O-C-N 118.821 -2.424 . . . . 0.0 110.704 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' O ' ' A' ' 7' ' ' THR . 28.0 t 127.28 -62.78 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.821 0 N-CA-C 102.466 -3.161 . . . . 0.0 102.466 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 8' ' ' SER 0.272 6.1 t0 -14.91 -71.77 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 125.805 1.941 . . . . 0.0 111.165 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -25.46 -53.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 CA-C-N 111.938 -2.392 . . . . 0.0 111.764 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 39.2 t -47.38 -56.19 7.4 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 113.908 -1.496 . . . . 0.0 110.852 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -73.84 -39.33 64.09 Favored 'General case' 0 N--CA 1.509 2.506 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.4 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -47.01 -56.18 6.89 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.3 mt -44.16 -65.86 0.46 Allowed 'General case' 0 N--CA 1.508 2.471 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.15 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -51.13 -52.8 40.34 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 121.335 0.588 . . . . 0.0 110.792 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.33 -54.96 17.92 Favored Glycine 1 N--CA 1.522 4.385 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -49.58 -61.19 2.25 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.508 -1.346 . . . . 0.0 108.648 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . -50.68 -55.55 15.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 125.771 1.919 . . . . 0.0 113.632 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' ALA . . . -35.93 -58.69 0.63 Allowed 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.859 0.838 . . . . 0.0 109.36 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.511 ' HB2' ' NZ ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -53.71 -66.68 0.35 Allowed 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 123.112 1.434 . . . . 0.0 110.196 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' OE2' ' NZ ' ' A' ' 20' ' ' LYS . 0.2 OUTLIER -41.16 -44.33 2.53 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.706 -1.588 . . . . 0.0 112.18 179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 23' ' ' ILE . 13.7 m-85 -74.65 -46.89 35.12 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -44.78 -45.33 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.5 -58.68 4.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -35.96 -50.03 0.66 Allowed 'General case' 0 N--CA 1.511 2.592 0 CA-C-O 124.007 1.861 . . . . 0.0 111.887 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.9 mt -76.97 50.95 0.76 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 111.431 -2.622 . . . . 0.0 112.98 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.8 t 42.44 49.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 124.626 2.155 . . . . 0.0 108.256 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HB3' ' HZ3' ' A' ' 28' ' ' LYS . 6.3 mtpm? 55.01 60.67 3.33 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 111.553 -2.567 . . . . 0.0 117.438 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.06 -14.79 5.92 Favored Glycine 1 N--CA 1.518 4.153 0 N-CA-C 122.923 3.929 . . . . 0.0 122.923 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.577 ' HB2' HH11 ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.58 0 CA-C-N 120.807 2.303 . . . . 0.0 110.032 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 2' ' ' ALA . 54.6 t-80 . . . . . 0 N--CA 1.507 2.4 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.432 ' N ' ' ND1' ' A' ' 1' ' ' HIS . . . -139.22 -89.92 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 125.21 1.569 . . . . 0.0 106.791 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -112.82 -21.45 11.17 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 125.291 1.436 . . . . 0.0 112.821 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 127.91 -30.55 3.91 Favored Glycine 0 N--CA 1.513 3.785 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.019 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.44 ' H ' ' HG2' ' A' ' 3' ' ' GLU . 69.8 m -145.11 49.08 1.27 Allowed 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -47.05 150.01 0.84 Allowed 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 8' ' ' SER . 2.0 t -133.99 -57.62 0.86 Allowed 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 7' ' ' THR . 39.5 p -45.48 -37.51 5.32 Favored 'General case' 0 N--CA 1.521 3.102 0 CA-C-O 122.75 1.262 . . . . 0.0 111.355 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -73.24 -68.78 0.47 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.1 t -27.63 -55.64 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.674 0 C-N-CA 123.341 0.656 . . . . 0.0 112.747 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 88.8 p -58.15 -60.97 2.92 Favored 'General case' 0 N--CA 1.513 2.715 0 C-N-CA 119.428 -0.909 . . . . 0.0 109.227 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 m -46.75 -53.12 12.5 Favored 'General case' 0 N--CA 1.511 2.598 0 CA-C-O 123.689 1.709 . . . . 0.0 109.924 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -48.9 -58.31 5.05 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 113.306 -1.77 . . . . 0.0 109.86 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 tp -57.59 -53.27 60.03 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.009 -1.451 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -44.39 -56.48 4.2 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.35 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -36.34 -32.66 0.05 OUTLIER Glycine 1 N--CA 1.522 4.422 0 CA-C-O 123.917 1.843 . . . . 0.0 112.561 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.494 ' NE2' ' HG2' ' A' ' 21' ' ' GLU . 13.1 tp60 -102.61 -51.03 3.41 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.722 -1.239 . . . . 0.0 109.274 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.83 -49.24 3.16 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 122.027 0.917 . . . . 0.0 110.772 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.98 -51.52 63.64 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 123.084 1.421 . . . . 0.0 109.057 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -59.08 -53.67 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.752 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.494 ' HG2' ' NE2' ' A' ' 17' ' ' GLN . 0.6 OUTLIER -60.9 -19.82 61.04 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.047 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -77.23 -52.31 9.45 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.3 mt -48.26 -45.26 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 124.086 1.898 . . . . 0.0 107.006 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.48 60.42 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 113.303 -1.771 . . . . 0.0 111.472 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.407 ' N ' ' O ' ' A' ' 21' ' ' GLU . 26.0 t90 -43.25 -48.57 6.68 Favored 'General case' 0 N--CA 1.515 2.817 0 CA-C-O 122.332 1.063 . . . . 0.0 108.745 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.6 mm? -58.98 -59.63 5.16 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 t -45.59 -23.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.773 0 CA-C-N 114.2 -1.363 . . . . 0.0 113.15 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.69 -28.06 53.59 Favored 'General case' 0 N--CA 1.516 2.851 0 O-C-N 121.69 -0.631 . . . . 0.0 110.775 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -85.21 -37.62 9.75 Favored Glycine 1 N--CA 1.517 4.096 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.546 ' NH2' ' C ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.025 0 C-N-CA 130.027 3.331 . . . . 0.0 116.551 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' GLY . 34.8 m170 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 117.716 2.487 . . . . 0.0 117.716 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.87 -42.63 4.65 Favored 'General case' 0 N--CA 1.519 2.98 0 CA-C-O 123.502 1.62 . . . . 0.0 111.117 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.555 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -89.04 -18.54 27.12 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 111.665 -2.516 . . . . 0.0 112.717 179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 1' ' ' HIS . . . 148.84 -148.85 20.65 Favored Glycine 1 N--CA 1.517 4.099 0 N-CA-C 115.644 1.018 . . . . 0.0 115.644 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -109.7 164.25 12.73 Favored 'General case' 0 N--CA 1.524 3.266 0 O-C-N 122.455 -0.438 . . . . 0.0 111.943 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 10' ' ' VAL . 13.8 t80 63.47 33.18 13.82 Favored 'General case' 0 N--CA 1.516 2.837 0 CA-C-O 123.551 1.644 . . . . 0.0 109.931 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.467 HG21 ' HG2' ' A' ' 3' ' ' GLU . 73.2 p -121.15 -64.86 1.19 Allowed 'General case' 0 N--CA 1.528 3.428 0 O-C-N 121.187 -0.946 . . . . 0.0 112.416 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' N ' ' OG1' ' A' ' 7' ' ' THR . 0.0 OUTLIER -95.06 -25.75 16.33 Favored 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 179.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . 0.334 16.6 t0 -69.37 -176.23 0.93 Allowed 'General case' 0 CA--C 1.58 2.118 0 N-CA-C 100.771 -3.789 . . . . 0.0 100.771 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.453 HG21 ' CD1' ' A' ' 6' ' ' PHE . 11.1 t 45.29 20.89 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.686 0 O-C-N 118.726 -2.484 . . . . 0.0 113.295 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 14' ' ' LEU . 70.6 m 71.37 53.65 0.23 Allowed 'General case' 0 N--CA 1.518 2.974 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.0 m 58.6 35.42 24.52 Favored 'General case' 0 N--CA 1.526 3.369 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 1.7 t80 45.37 49.93 10.17 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 127.027 3.298 . . . . 0.0 103.256 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' SER 0.36 0.3 OUTLIER 50.93 53.6 12.75 Favored 'General case' 0 N--CA 1.496 1.853 1 CA-C-N 107.456 -4.429 . . . . 0.0 106.414 -179.481 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 34.18 65.11 0.33 Allowed 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 127.179 3.371 . . . . 0.0 108.813 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.7 47.27 92.02 Favored Glycine 0 N--CA 1.515 3.956 0 CA-C-N 109.331 -3.577 . . . . 0.0 105.529 -179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.54 ' HG2' ' HB2' ' A' ' 20' ' ' LYS . 0.0 OUTLIER 28.96 62.99 0.13 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 124.515 2.102 . . . . 0.0 110.533 -179.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 23' ' ' ILE . . . 33.89 58.3 0.58 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-N 108.742 -3.845 . . . . 0.0 111.973 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 51.35 47.89 24.0 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 111.033 -2.803 . . . . 0.0 109.597 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB2' ' HG2' ' A' ' 17' ' ' GLN 0.295 28.0 ttpp 6.11 -73.99 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.545 2.424 . . . . 0.0 117.545 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -41.11 -32.5 0.26 Allowed 'General case' 0 N--CA 1.511 2.62 0 CA-C-O 123.991 1.853 . . . . 0.0 111.663 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 23' ' ' ILE . 46.8 t80 -91.54 -51.0 5.48 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.815 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.451 ' CG1' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -45.28 -43.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 CA-C-N 120.984 1.72 . . . . 0.0 107.906 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -45.81 -52.36 11.36 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.432 ' O ' ' NH1' ' A' ' 30' ' ' ARG . 25.4 t90 -47.91 -28.08 2.49 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 113.536 -1.665 . . . . 0.0 112.447 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 26' ' ' LEU . 3.1 mm? -93.43 -21.05 19.74 Favored 'General case' 0 N--CA 1.51 2.564 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 m -105.92 -31.25 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.929 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -139.08 29.15 2.27 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-O 122.695 1.236 . . . . 0.0 110.388 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.15 9.01 5.11 Favored Glycine 0 N--CA 1.512 3.756 0 CA-C-N 113.375 -1.739 . . . . 0.0 111.744 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.735 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.965 0 O-C-N 125.862 1.566 . . . . 0.0 109.242 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.527 ' N ' ' OE1' ' A' ' 3' ' ' GLU . 13.5 m170 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 116.12 -1.895 . . . . 0.0 106.299 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' A' ' 8' ' ' SER . . . 82.71 23.75 0.17 Allowed 'General case' 0 N--CA 1.527 3.421 0 O-C-N 125.357 1.661 . . . . 0.0 112.135 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -122.5 -44.91 2.22 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.445 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.447 ' N ' ' HG2' ' A' ' 3' ' ' GLU . . . -117.85 -52.19 0.32 Allowed Glycine 0 N--CA 1.515 3.962 0 N-CA-C 117.985 1.954 . . . . 0.0 117.985 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 6' ' ' PHE . 50.9 m -149.64 166.41 29.39 Favored 'General case' 0 N--CA 1.524 3.229 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.455 ' N ' HG22 ' A' ' 5' ' ' THR . 20.4 m-85 -31.72 66.11 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 118.932 2.938 . . . . 0.0 118.932 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.517 ' HB ' ' CG ' ' A' ' 1' ' ' HIS . 36.2 p -119.36 -24.92 6.21 Favored 'General case' 0 N--CA 1.517 2.919 0 CA-C-O 122.878 1.323 . . . . 0.0 111.282 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' CB ' ' HB2' ' A' ' 2' ' ' ALA . 42.4 t -124.98 -58.62 1.46 Allowed 'General case' 0 N--CA 1.518 2.926 0 CA-C-O 124.983 2.325 . . . . 0.0 105.267 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -25.24 -54.61 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 109.065 -3.698 . . . . 0.0 109.116 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.5 t -22.92 -51.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.658 0 CA-C-N 111.639 -2.528 . . . . 0.0 112.468 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.2 m -28.86 -48.82 0.07 Allowed 'General case' 0 N--CA 1.516 2.845 0 CA-C-N 114.625 -1.17 . . . . 0.0 113.392 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 14' ' ' LEU . 23.0 m -78.94 -47.21 16.82 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 114.2 -1.364 . . . . 0.0 108.498 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' CZ ' ' NZ ' ' A' ' 20' ' ' LYS . 44.6 t80 -38.25 -32.96 0.08 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-O 121.847 0.832 . . . . 0.0 111.069 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 12' ' ' SER . 4.5 mm? -76.01 -49.86 16.43 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 112.931 -1.94 . . . . 0.0 108.953 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -47.14 81.59 Favored 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.47 -37.42 74.78 Favored Glycine 0 N--CA 1.503 3.139 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 4.4 tp60 -56.02 -53.44 56.94 Favored 'General case' 0 N--CA 1.516 2.866 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.53 -52.04 60.93 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.09 -56.17 8.44 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' NZ ' ' CZ ' ' A' ' 13' ' ' TYR . 72.1 mttt -46.75 -56.07 6.81 Favored 'General case' 0 N--CA 1.513 2.724 0 CA-C-O 121.932 0.872 . . . . 0.0 110.223 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 3.8 tp10 -57.46 -37.15 72.41 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 121.92 0.867 . . . . 0.0 112.173 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 21.2 t80 -64.96 -45.14 86.99 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 104.972 -2.233 . . . . 0.0 104.972 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.7 mm -54.62 -55.35 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -50.58 -40.42 52.39 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.828 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.404 ' CZ2' ' NE ' ' A' ' 30' ' ' ARG . 3.4 t90 -43.34 -29.46 0.42 Allowed 'General case' 0 N--CA 1.509 2.515 0 C-N-CA 124.209 1.003 . . . . 0.0 113.684 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 26' ' ' LEU . 9.7 mp -99.27 15.11 27.2 Favored 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 123.778 1.752 . . . . 0.0 115.686 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.99 -42.87 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.544 0 CA-C-O 124.896 2.284 . . . . 0.0 106.365 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 5.9 ttpt -111.33 68.56 0.67 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 111.598 -2.546 . . . . 0.0 111.463 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 148.3 -73.66 0.29 Allowed Glycine 1 N--CA 1.525 4.582 0 N-CA-C 122.494 3.758 . . . . 0.0 122.494 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.551 ' NH1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.581 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.675 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.21 -31.94 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 C-N-CA 125.815 1.646 . . . . 0.0 107.334 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.675 ' CD ' ' H2 ' ' A' ' 1' ' ' HIS . 0.0 OUTLIER -92.42 -64.4 1.11 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 111.65 -2.523 . . . . 0.0 111.479 179.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.469 ' H ' ' CG ' ' A' ' 3' ' ' GLU . . . -155.35 -69.27 0.01 OUTLIER Glycine 0 N--CA 1.512 3.762 0 N-CA-C 107.715 -2.154 . . . . 0.0 107.715 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 p -114.52 -79.75 0.59 Allowed 'General case' 0 N--CA 1.508 2.475 0 CA-C-N 112.564 -1.818 . . . . 0.0 108.756 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -156.16 116.71 3.72 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.3 p -32.09 -30.82 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.169 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -89.41 -14.65 35.01 Favored 'General case' 0 N--CA 1.516 2.867 0 N-CA-C 115.845 1.794 . . . . 0.0 115.845 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -49.22 -43.83 42.82 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 124.563 2.125 . . . . 0.0 105.972 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.4 t -49.91 -51.51 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.311 0 CA-C-N 112.009 -2.36 . . . . 0.0 106.732 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -55.6 -65.99 0.5 Allowed 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.5 t -32.63 -53.85 0.34 Allowed 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.736 1.255 . . . . 0.0 111.916 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -59.56 -46.03 90.1 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.314 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 17' ' ' GLN . 5.2 tt -63.94 -62.04 1.89 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER -41.65 -51.33 4.06 Favored 'General case' 0 N--CA 1.509 2.485 0 CA-C-N 120.706 1.593 . . . . 0.0 108.15 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -51.7 -46.52 54.0 Favored Glycine 0 N--CA 1.512 3.755 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.06 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.546 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 16.9 mm100 -28.55 -51.69 0.09 Allowed 'General case' 0 N--CA 1.513 2.705 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -11.05 -56.16 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.98 -56.81 4.62 Favored 'General case' 0 N--CA 1.505 2.292 0 CA-C-O 122.275 1.036 . . . . 0.0 108.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -48.7 -50.95 31.14 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-O 123.569 1.652 . . . . 0.0 106.979 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.524 ' CG ' ' HB3' ' A' ' 17' ' ' GLN . 18.1 mm-40 -54.29 -36.92 64.2 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 113.278 -1.783 . . . . 0.0 112.373 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.528 ' HA ' ' HB2' ' A' ' 25' ' ' TRP . 13.6 t80 -73.55 -46.24 48.7 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.461 ' O ' HD22 ' A' ' 26' ' ' LEU . 95.8 mt -57.11 -49.34 79.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 CA-C-N 114.03 -1.441 . . . . 0.0 110.543 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.48 -24.59 42.22 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 123.899 1.809 . . . . 0.0 109.384 179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HB2' ' HA ' ' A' ' 22' ' ' PHE . 2.3 t90 -27.65 -58.15 0.11 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 23' ' ' ILE 0.269 0.4 OUTLIER -47.58 -13.99 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 -179.244 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.3 t -99.62 -28.1 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' A' ' 21' ' ' GLU . 13.7 ptmt -121.97 52.96 1.23 Allowed 'General case' 0 CA--C 1.582 2.176 0 CA-C-N 112.246 -2.252 . . . . 0.0 114.466 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.97 -66.77 0.42 Allowed Glycine 1 N--CA 1.534 5.178 1 N-CA-C 127.023 5.569 . . . . 0.0 127.023 179.61 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.655 HH11 ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.526 3.337 0 CA-C-N 121.915 2.858 . . . . 0.0 117.186 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.601 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 16.9 m-70 . . . . . 0 N--CA 1.497 1.897 0 N-CA-C 117.087 2.254 . . . . 0.0 117.087 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -44.78 -42.18 7.56 Favored 'General case' 0 N--CA 1.521 3.114 0 CA-C-O 124.571 2.129 . . . . 0.0 112.104 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.774 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -90.35 17.05 7.66 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-N 109.928 -3.306 . . . . 0.0 114.598 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.17 -64.38 0.26 Allowed Glycine 0 N--CA 1.506 3.362 0 CA-C-N 114.773 -1.103 . . . . 0.0 115.159 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.6 p -124.23 -72.82 0.66 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 1' ' ' HIS . 48.5 m-85 -1.48 135.14 0.0 OUTLIER 'General case' 0 N--CA 1.519 2.994 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.0 p -132.6 -79.16 0.5 Allowed 'General case' 0 N--CA 1.522 3.158 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 p -40.79 -36.96 0.69 Allowed 'General case' 0 N--CA 1.526 3.353 0 CA-C-O 124.735 2.207 . . . . 0.0 110.907 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -34.9 -53.42 0.56 Allowed 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 109.774 -3.376 . . . . 0.0 109.226 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 83.5 t -46.35 -51.36 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.438 0 CA-C-O 123.308 1.528 . . . . 0.0 109.559 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.1 t -67.5 -47.07 71.06 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -43.84 -51.73 7.23 Favored 'General case' 0 N--CA 1.521 3.084 0 CA-C-O 122.689 1.233 . . . . 0.0 107.761 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.401 ' O ' ' C ' ' A' ' 14' ' ' LEU . 6.9 t80 -64.56 -59.09 4.71 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.768 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' C ' HD23 ' A' ' 14' ' ' LEU . 6.0 tt -33.12 -61.16 0.31 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 123.802 0.689 . . . . 0.0 109.8 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HA ' ' H ' ' A' ' 19' ' ' ALA . 16.8 mm-40 -73.66 -42.0 61.95 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 122.822 1.296 . . . . 0.0 108.692 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.521 ' O ' ' NZ ' ' A' ' 20' ' ' LYS . . . -33.86 -43.23 0.28 Allowed Glycine 1 N--CA 1.519 4.228 0 N-CA-C 108.149 -1.98 . . . . 0.0 108.149 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -103.39 -49.91 3.59 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 112.936 -1.632 . . . . 0.0 114.151 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.66 -47.68 52.65 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 15' ' ' GLU . . . -19.86 -49.26 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 16' ' ' GLY . 13.6 mptt -19.17 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 CA-C-N 112.611 -2.086 . . . . 0.0 115.751 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.411 ' OE1' ' NZ ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -102.04 -30.3 11.27 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.185 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -57.6 -42.35 83.05 Favored 'General case' 0 N--CA 1.513 2.682 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.7 mt -47.42 -40.57 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.446 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.15 -35.52 21.66 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 113.06 -1.882 . . . . 0.0 108.493 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' CD1' ' NZ ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -52.78 -49.06 66.34 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 119.844 -1.785 . . . . 0.0 106.824 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 26' ' ' LEU . 10.8 mp -79.21 17.85 0.74 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER -121.83 -48.0 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.518 ' NZ ' ' CD1' ' A' ' 25' ' ' TRP . 58.1 mttt -19.12 -38.33 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 27' ' ' VAL . . . -129.72 13.16 5.87 Favored Glycine 1 N--CA 1.523 4.487 0 N-CA-C 116.945 1.538 . . . . 0.0 116.945 179.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.895 ' NH2' ' HB2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.528 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.1 m80 . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.08 -46.87 6.31 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 121.956 2.162 . . . . 0.0 106.92 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.538 ' CD ' ' H ' ' A' ' 4' ' ' GLY . 0.0 OUTLIER -91.2 -47.38 7.55 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 112.054 -2.339 . . . . 0.0 109.204 179.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.538 ' H ' ' CD ' ' A' ' 3' ' ' GLU . . . -97.72 85.98 0.79 Allowed Glycine 0 N--CA 1.509 3.564 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.018 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 6' ' ' PHE . 2.4 m -132.27 170.06 15.59 Favored 'General case' 0 N--CA 1.512 2.637 0 CA-C-N 114.179 -1.011 . . . . 0.0 108.389 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 5' ' ' THR . 3.3 m-85 -64.55 55.05 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 119.089 2.996 . . . . 0.0 119.089 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.8 p -142.26 -63.42 0.43 Allowed 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 101.372 -3.566 . . . . 0.0 101.372 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.0 m -69.41 -58.55 3.85 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 111.637 -2.529 . . . . 0.0 107.491 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.18 -55.18 16.2 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.6 t -50.79 -62.07 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 114.568 -1.197 . . . . 0.0 110.036 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.4 m -47.27 -50.58 21.12 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.261 0.553 . . . . 0.0 110.832 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.3 t -58.24 -54.31 48.38 Favored 'General case' 0 N--CA 1.514 2.747 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.22 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -44.4 -57.1 3.74 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.158 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 49.7 tp -34.2 -46.81 0.26 Allowed 'General case' 0 N--CA 1.51 2.562 0 O-C-N 124.92 1.387 . . . . 0.0 111.702 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -84.56 -60.0 2.2 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.113 -1.858 . . . . 0.0 107.184 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -30.63 -37.9 0.02 OUTLIER Glycine 1 N--CA 1.524 4.558 0 CA-C-O 123.876 1.82 . . . . 0.0 112.8 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.413 ' O ' ' HE2' ' A' ' 20' ' ' LYS . 5.1 tt0 -86.21 -90.95 0.1 Allowed 'General case' 0 CA--C 1.573 1.838 0 N-CA-C 104.524 -2.398 . . . . 0.0 104.524 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -21.68 -49.19 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -37.12 -34.6 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 113.505 -1.68 . . . . 0.0 114.594 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -102.58 -53.59 2.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.51 ' N ' ' HG2' ' A' ' 20' ' ' LYS . 4.3 pm0 -48.09 -34.38 9.59 Favored 'General case' 0 N--CA 1.508 2.448 0 CA-C-N 121.226 1.83 . . . . 0.0 112.803 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 25' ' ' TRP . 1.6 t80 -81.05 -38.44 27.4 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 25' ' ' TRP . 2.5 tp -56.27 -43.79 77.74 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.491 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.69 24.41 0.06 Allowed 'General case' 0 CA--C 1.575 1.923 0 CA-C-N 114.229 -1.351 . . . . 0.0 111.97 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.488 ' H ' ' C ' ' A' ' 23' ' ' ILE . 67.4 t90 -127.28 -62.38 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 102.695 -3.076 . . . . 0.0 102.695 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.9 mt -58.9 -31.65 68.82 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 111.42 -2.627 . . . . 0.0 113.007 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.4 t -107.46 -35.72 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.434 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.062 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 28' ' ' LYS . 3.5 ttpt -113.81 20.24 16.0 Favored 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.84 -9.16 5.87 Favored Glycine 1 N--CA 1.527 4.755 0 O-C-N 121.781 -0.574 . . . . 0.0 113.167 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' H ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.176 0 O-C-N 126.029 1.664 . . . . 0.0 111.189 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . 0.546 ' CD2' ' H ' ' A' ' 2' ' ' ALA . 15.9 t-160 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 116.705 -1.617 . . . . 0.0 106.888 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.546 ' H ' ' CD2' ' A' ' 1' ' ' HIS . . . 38.14 32.18 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.763 0 CA-C-O 124.176 1.941 . . . . 0.0 107.944 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.627 ' H ' ' CD ' ' A' ' 3' ' ' GLU 0.258 0.0 OUTLIER 4.64 61.73 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 110.248 -3.16 . . . . 0.0 112.889 -178.906 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 2' ' ' ALA . . . 15.26 46.24 0.01 OUTLIER Glycine 1 N--CA 1.522 4.382 1 CA-C-N 106.164 -5.016 . . . . 0.0 117.113 -179.979 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.404 ' CB ' ' O ' ' A' ' 4' ' ' GLY . 82.6 m 104.22 48.49 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.625 0 O-C-N 126.145 1.732 . . . . 0.0 114.257 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -55.06 67.44 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 9' ' ' ASP . 2.2 t -89.87 -158.5 0.53 Allowed 'General case' 0 N--CA 1.512 2.644 0 CA-C-N 113.86 -1.518 . . . . 0.0 109.362 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -9.89 -33.32 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 120.825 3.639 . . . . 0.0 120.825 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.5 OUTLIER -89.18 -82.1 0.26 Allowed 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 127.373 2.269 . . . . 0.0 108.89 -179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.1 t -52.72 -39.4 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.7 m -56.46 -68.89 0.17 Allowed 'General case' 0 N--CA 1.512 2.65 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -36.31 -49.08 0.68 Allowed 'General case' 0 N--CA 1.516 2.831 0 O-C-N 124.64 1.213 . . . . 0.0 111.807 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -59.11 -59.03 6.12 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 118.96 -1.096 . . . . 0.0 111.221 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 14' ' ' LEU . 6.1 tt -53.53 -53.08 56.68 Favored 'General case' 0 N--CA 1.513 2.693 0 CA-C-O 123.879 1.8 . . . . 0.0 108.732 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . 0.312 86.0 tt0 -46.15 -64.93 0.63 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 111.97 -2.377 . . . . 0.0 106.327 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.19 -56.75 9.93 Favored Glycine 0 N--CA 1.507 3.419 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -48.21 -40.84 25.63 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.94 -27.15 23.5 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.271 1.034 . . . . 0.0 112.978 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.19 -42.9 15.48 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.602 ' HZ3' ' CD ' ' A' ' 21' ' ' GLU . 13.9 pttp -31.03 -61.0 0.2 Allowed 'General case' 0 N--CA 1.516 2.844 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.602 ' CD ' ' HZ3' ' A' ' 20' ' ' LYS . 17.2 mp0 -50.1 -48.17 53.47 Favored 'General case' 0 N--CA 1.51 2.565 0 CA-C-N 120.484 1.493 . . . . 0.0 112.882 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.41 ' CE1' HD22 ' A' ' 26' ' ' LEU . 33.5 t80 -64.7 -44.66 89.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.299 1.047 . . . . 0.0 108.295 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 84.6 mt -52.26 -54.34 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.65 -58.6 6.3 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.446 ' CD1' ' O ' ' A' ' 21' ' ' GLU . 45.5 m0 -32.11 -56.54 0.31 Allowed 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 26' ' ' LEU . 11.1 mp -90.37 -30.03 17.68 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.0 t -77.91 -53.15 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 O-C-N 121.953 -0.467 . . . . 0.0 110.502 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.521 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 4.9 tptp -122.65 -8.19 8.51 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.86 -28.04 46.19 Favored Glycine 1 N--CA 1.529 4.89 0 N-CA-C 106.08 -2.808 . . . . 0.0 106.08 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HB3' ' CZ ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.631 0 CA-C-N 109.655 -3.273 . . . . 0.0 103.11 179.35 . . . . . . . . 2 2 . 1 stop_ save_